DRAFT 

REPORT TO THE ADVISORY BOARD 

ON RADIATION AND WORKER HEALTH

National Institute for Occupational Safety and Health 

COMPARISON OF SC&A’S BLIND DOSE RECONSTRUCTION 

TO NIOSH’S DOSE RECONSTRUCTION OF CASE #[REDACT] 

FROM THE NEVADA TEST SITE 

Contract No. 211-2014-58081 

SCA-TR-DRC2015-CN[Redact]

Prepared by 

Ron Buchanan, PhD, CHP 

S. Cohen & Associates 

1608 Spring Hill Road, Suite 400 

Vienna, Virginia 22182 

April 2015 

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

2 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

S. Cohen & Associates:

Technical Support for the Advisory Board on

Radiation & Worker Health Review of

NIOSH Dose Reconstruction Program

Document No. 

SCA-TR-DRC2015-CN[Redact]

Effective Date: 

Draft – April 13, 2015

Comparison of SC&A’s Blind Dose 

Reconstruction to NIOSH’s Dose Reconstruction 

of Case #[Redact] from the Nevada Test Site

Page 2 of 21

Task Manager:

________________________ Date: ___________

Rose Gogliotti,

Supersedes:

N/A

Project Manager:

________________________ Date: ___________

John Stiver, MS, CHP

Reviewers:

 Kathleen Behling

 Rose Gogliotti

 John Stiver

Record of Revisions

Revision 

Number Effective Date Description of Revision

0 (Draft) 04/13/2015 Initial issued.
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

3 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

TABLE OF CONTENTS 

Abbreviations and Acronyms ..........................................................................................................5

1.0 Relevant Background Information .......................................................................................6

2.0 Comparison of Methodology/Doses used by SC&A and NIOSH for Case #[Redact] ........8

2.1 Occupational External Dose Calculations .............................................................11

2.1.1 Recorded Photon and Electron Doses ........................................................11

2.1.2 Missed Photon and Electron Doses............................................................12

2.1.3 Onsite Ambient Doses ...............................................................................13

2.1.4 Occupational Medical Doses .....................................................................13

2.2 Occupational Internal Doses ..................................................................................14

2.2.1 Internal Environmental Dose .....................................................................14

3.0 Summary Conclusions .......................................................................................................16

4.0 References ..........................................................................................................................19

Addendum A: SC&A’s Blind DR Report for Case #[Redact] .....................................................21
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

4 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

LIST OF TABLES 

Table 1-1. Comparison of SC&A’s Blind Dose Reconstruction to NIOSH’s Dose 

Reconstruction for Case #[Redact] ...............................................................................7

Table 2-1. Summary of Cancers .....................................................................................................8

Table 2-2. Comparison of External Dose Data and Assumptions Used by 

SC&A and NIOSH .......................................................................................................9

Table 2-3. Comparison of Internal Dose Data and Assumptions Used by 

SC&A and NIOSH .....................................................................................................11

Table 2-4. Comparison of Recorded Photon Doses ......................................................................12

Table 2-5. Comparison of Missed Photon and Electron Doses ....................................................13

Table 2-6. Comparison of Occupational Medical Doses ..............................................................14

Table 2-7. Comparison of Internal Environmental Doses ............................................................15

Table 3-1. Comparison of SC&A’s and NIOSH’s Total External and Internal Dose 

Estimates for the 8 Cancers ........................................................................................16
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

5 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

ABBREVIATIONS AND ACRONYMS 

Advisory Board Advisory Board on Radiation and Worker Health 

BCC basil cell carcinoma 

CADW chronic annual dose workbook 

CATI Computer-Assisted Telephone Interview 

DCF dose conversion factors 

DOE (U.S.) Department of Energy 

DOL (U.S.) Department of Labor 

DR dose reconstruction 

ENSD entrance skin dose 

EE energy employee 

GSD geometric standard deviation 

ICD International Classification of Diseases 

ICRP International Commission on Radiological Protection 

IREP Interactive RadioEpidemiological Program 

keV kilo electron volt; 1,000 electron volts 

LAT lateral 

LOD limit of detection

NIOSH National Institute for Occupational Safety and Health 

NTS Nevada Test Site 

PA posterior-anterior 

POC probability of causation 

RBM red bone marrow 

rem Roentgen equivalent man 

SC&A S. Cohen and Associates (SC&A, Inc.) 

SCC squamous cell carcinoma 

SEC Special Exposure Cohort 

TBD technical basis document 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

6 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

1.0 RELEVANT BACKGROUND INFORMATION 

Under Contract No. 211-2014-58081, SC&A was tasked by the Advisory Board on Radiation 

and Worker Health (Advisory Board) to perform six blind dose reconstructions (DRs) at the July 

2014, DR Subcommittee meeting. SC&A was provided all of the Department of Energy (DOE) 

dosimetry records; the Department of Labor (DOL) correspondence, forms, and medical records; 

and the Computer-Assisted Telephone Interview (CATI) Reports that were made available to the 

National Institute for Occupational Safety and Health (NIOSH) for constructing doses in behalf 

of these cases. SC&A used an independent approach to reconstruct occupational external and 

internal doses for the cases using the available dosimetry records and current guidance from 

NIOSH; including the spreadsheets and other tools developed by NIOSH to calculate the doses. 

On February 12, 2015, SC&A submitted to the Advisory Board and NIOSH, a memorandum 

containing the summary results of our blind DR in behalf of Case #[Redact]. After reviewing 

our draft DR blind report, it was determined that there was a slight error in calculating external 

doses for two of the eight cancers. Therefore, SC&A resubmitted the corrected total doses and 

resultant Probability of Causation (POC) for this case in a memo dated March 16, 2015. The 

complete DR report titled SC&A’s Dose Reconstruction of Case #[Redact] from the Nevada Test 

Site (SCA-TR-BDR2015-CN[Redact]), which provides the assumptions and methodologies used 

to derive occupational radiation doses and resultant POC, is included herein as Addendum A.

In this report, SC&A presents a comparison between NIOSH’s and SC&A’s DR methodologies, 

doses, and resultant POC values for Case #[Redact]. Table 1-1 summarizes the external and 

internal occupational doses calculated by SC&A and the NIOSH-assigned doses for the eight 

cancers diagnosed in behalf of Case #[Redact]. A detailed comparison of the two 

methodologies used to calculate doses in behalf of this case is presented in Section 2. Section 3 

of this report provides Summary Conclusions. 

It should be noted that, where appropriate, an explanation is provided regarding the differences 

in doses and why they occurred; however, SC&A does not make any value judgments regarding 

which among them may be the more preferred approach. It is our position that further 

discussions are best addressed by the DR Subcommittee. 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

7 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table 1-1. Comparison of SC&A’s Blind Dose Reconstruction to NIOSH’s Dose Reconstruction for Case #[Redact]

SC&A

#1

[redact]

[redact]

Dose

(rem)

NIOSH

#1

[redact]

[redact]

Dose

(rem)

SC&A

#2

Scalp

[redact]

Dose

(rem)

NIOSH

#2

Scalp

[redact]

Dose

(rem)

SC&A

#3

Prostate

[redact]

Dose

(rem)

NIOSH

#3

Prostate

[redact]

Dose

(rem)

SC&A

#4

Neck

[redact]

Dose

(rem)

NIOSH

#4

Neck

[redact]

Dose

(rem)

SC&A

#5

Neck

[redact]

Dose

(rem)

NIOSH

#5

Neck

[redact]

Dose

(rem)

SC&A

#6

[redact]

[redact]

Dose

(rem)

NIOSH

#6

[redact]

[redact]

Dose

(rem)

SC&A

#7

Thromb.

[redact]

Dose

(rem)

NISOH

#7

Thromb.

[redact]

Dose

(rem)

SC&A

#8

[redact]

[redact]

Dose

(rem)

NIOSH

#8

[redact]

[redact]

Dose

(rem)

External Dose 

 ▪ Recorded Dose:

 30–250 keV Photons - - 0.011 0.011 0.014 0.018 0.011 0.011 0.011 0.011 0.011 0.011 0.007 .014 0.011 0.011

 >250 keV Photons - - 0.039 0.039 0.034 0.051 0.039 0.039 0.039 0.039 0.039 0.039 0.028 0.051 0.039 0.039

 ▪ Missed Dose:

 >15 keV Electrons - - 0.015 0.015 - - 0.015 0.015 0.015 0.015 0.015 0.015 - - 0.015 0.015

 30–250 keV Photons 2.140 2.280 3.550 3.600 0.972 0.969 3.550 3.600 3.550 3.600 3.550 3.600 0.489 0.779 3.550 3.600

 >250 keV Photons - - - - 2.445 2.761 - - - - - - 1.994 2.761 - -

 ▪ Occup. Medical Dose:

 30–250 keV Photons 0.113 0.113 0.042 0.042 0.003 0.003 0.069 0.069 0.069 0.069 0.031 0.032 0.021 0.021 0.032 0.032

Internal Dose, environ.:

 Alpha 0.001 0.001 0.006 0.006 0.006 0.006 0.006 0.006 0.006 0.006 0.007 0.007 0.208 0.208 0.007 0.007

 >250 keV Photons 0.001 0.001 0.001 0.001 0.004 0.004 0.001 0.001 0.001 0.001 0.001 0.001 0.003 0.003 0.001 0.001

 >15 keV Electrons 0.001 0.001 0.002 0.002 0.003 0.003 0.002 0.002 0.002 0.002 0.002 0.002 0.023 0.023 0.002 0.002

Cancer total dose: 2.256 2.396 3.666 3.716 3.480 3.814 3.694 3.744 3.694 3.744 3.656 3.708 2.773 3.859 3.658 3.708

Cancer POC: 4.31% 4.31% 12.66% 10.88% 3.45% 3.83% 10.52% 11.24% 10.67% 11.16% 2.29% 2.32% 3.55% 4.74% 2.27% 2.23%

Combined POC: SC&A 40.59% NIOSH 41.17%
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

8 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

2.0 COMPARISON OF METHODOLOGY/DOSES USED BY SC&A AND 

NIOSH FOR CASE #[REDACT] 

Case #[Redact] represents an energy employee (EE) who worked as a [redact] at the Nevada 

Test Site (NTS) during the following periods:

 [redact]–[redact]

 [redact]–[redact]

 [redact]–[redact]

 [redact]–[redact]

The EE was diagnosed with eight cancers during the period [redact]–[redact], as summarized in 

Table 2-1:

Table 2-1. Summary of Cancers 

Cancer Cancer Site ICD-9 Code Year

#1 Malignant melanoma [redact] 172.5 [redact]

#2 BCC [redact] scalp 173.41 [redact]

#3 Prostate 185 [redact]

#4 BCC [redact] neck 173.41 [redact]

#5 Melanoma [redact] neck 172.4 [redact]

#6 SCC in-situ [redact] 232.32 [redact]

#7 Essential thrombocytosis 238.71 [redact]

#8 SCC in-situ [redact] 232.3 [redact]

BCC = Basil cell carcinoma, SCC = Squamous cell carcinoma 

This was a partial DR, because not all internal doses could be assigned prior to 1993, as per the 

NTS Special Exposure Cohort (SEC), which is discussed in ORAUT-TKBS-0008-5, page 12: 

NIOSH has determined, and the Secretary of Health and Human Services has 

concurred, that in the absence of bioassay results for the worker, internal doses 

cannot be reconstructed between 1951 and 1962 inclusive for an Energy 

Employee (EE). Based on the SEC petition evaluation, internal dose is not to be 

reconstructed for work before 1963 unless a worker has specific bioassay results 

that can be directly related to an event or incident. 

NIOSH has determined, and the Secretary of Health and Human Services has 

concurred that NIOSH lacks sufficient information that would allow it to 

adequately estimate internal exposures during the period 1963 through 1992. 

The EE was employed at NTS during the SEC period; however, since at least one of the cancers 

was a non-presumptive cancer, a DR was required. 

For calculating radiation dose from employment at NTS, both DR methods primarily relied on 

guidance in the NTS Technical Basis Document (TBD) (issued as six separate documents 

numbered ORAUT-TKBS-0008-1 through ORAUT-TKBS-0008-6). Using the guidance 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

9 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

provided in these documents, along with the employee’s dosimetry records, SC&A employed a 

best-estimate approach for calculating annual external and internal doses. NIOSH employed a 

combination of best-estimate and over-estimate approaches for calculating annual external doses 

and a best-estimate approach for internal doses. Both SC&A and NIOSH derived a probability 

of causation (POC) of <50%. 

A summary of the documents, assumptions, and dose parameters used by each DR method is 

provided in Tables 2-2 and 2-3 below: 

Table 2-2. Comparison of External Dose Data and Assumptions Used by 

SC&A and NIOSH

Parameters SC&A NIOSH

External Recorded Dose:

Records/Guidance 

Documents

DOE records, NTS TBD-6, OCAS-IG-001, 

OTIB-0005, & OTIB-0017.

DOE records, NTS TBD-6, OCAS-IG-001, 

OTIB-0005, OTIB-0017, & the NTS Dose 

Calculation Workbook 1.04.

Dose Determination 

Approach Best-estimate methodology. Best-estimate and some over-estimate 

methodology.

Work Locations [Redact] & [redact]. [Redact] & [redact].

Energy Range 22% 30–250 keV 

78% >250 keV

22% 30–250 keV 

78% >250 keV

Exposure Organ DCFs

Prostate:

30–250 keV DCF = 1.244

>250 keV DCF = 0.883

RBM:

30–250 keV DCF = 0.626

>250 keV DCF = 0.720

Skin:

30–250 keV DCF = 1.00

>250 keV DCF = 1.00

Prostate:

30–250 keV DCF = 1.244

>250 keV DCF = 1.00

RBM:

30–250 keV DCF = 1.00

>250 keV DCF = 1.00

Skin:

30–250 keV DCF = 1.00

>250 keV DCF = 1.00

Photon Dosimetry 

Correction Factor 1.25 <1966 1.25 <1966

ICRP-60 Correction F. NA NA

Neutron Fading F. NA NA

Dose Distribution

Prostate:

Normal; 30% uncertainty.

RBM:

Normal; 30% uncertainty.

Skin:

Normal; 30% uncertainty.

Prostate:

Constant, no uncertainty.

RBM:

Constant, no uncertainty.

Skin:

Constant, no uncertainty.

External Missed Dose:

Records/Guidance 

Documents

DOE records, NTS TBD-6, OCAS-IG-001, 

OTIB-0005, OTIB-0017, & PROC-0006.

DOE records, NTS TBD-6, OCAS-IG-001, 

OTIB-0005, OTIB-0017, PROC-0006, & 

the NTS Dose Calculation Workbook 1.04.

Dose Determination 

Approach Best-estimate methodology. Best-estimate and some over-estimate 

methodology.
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

10 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table 2-2. Comparison of External Dose Data and Assumptions Used by 

SC&A and NIOSH

Parameters SC&A NIOSH

No. of zeros

Prostate: 207 photons

RBM: 207 photons

Skin: 119 or 207 photons, 1 shallow.

Prostate: 207 photons

RBM: 207 photons

Skin: 119 or 207 photons, 1 shallow.

LOD Value

Skin, prostate, & RBM:

1962–Feb 1971: 0.040 rem

Mar 1971–1982: 0.030 rem

Skin: 1962–1971; 0.040 rem

Skin: 1972–1982; 0.030 rem

Prostate & RBM: 1962–1970; 0.040 rem

Prostate & RBM: 1971–1982; 0.030 rem

Energy Range

Prostate:

22% 30–250 keV

78% >250 keV

RBM:

22% 30–250 keV

78% >250 keV

Skin:

100% 30–250 keV

Prostate:

22% 30–250 keV

78% >250 keV

RBM:

22% 30–250 keV

78% >250 keV

Skin:

100% 30–250 keV

Exposure Organ DCFs

Prostate:

30–250 keV DCF = 1.244

>250 keV DCF = 0.883

RBM:

30–250 keV DCF = 0.626

>250 keV DCF = 0.720

Skin:

30–250 keV DCF = 1.00

Prostate:

30–250 keV DCF = 1.244

>250 keV DCF = 1.00

RBM:

30–250 keV DCF = 1.00

>250 keV DCF = 1.00

Skin:

30–250 keV DCF = 1.00

Photon Dosimetry 

Correction Factor 1.25 <1966 1.25 <1966

ICRP-60 Correction F. NA NA

Neutron Fading F. NA NA

Dose Distribution Lognormal with GSD = 1.52 Lognormal with GSD = 1.52

Coworker Dose:

NA NA

Shallow Dose:

Records/Guidance 

Documents

DOE records, NTS TBD-6, OCAS-IG-001, 

OTIB-0005, & OTIB-0017.

DOE records, NTS TBD-6, OCAS-IG-001, 

OTIB-0005, OTIB-0017, & the NTS Dose 

Calculation Workbook 1.04.

Energy Range >15 keV electrons >15 keV electrons

Exposure Organ DCFs 1.00 1.00

Dose Distribution Lognormal with 1.520 uncertainty. Lognormal with 1.520 uncertainty.

Onsite External Dose:

NA NA

Occupational Medical Dose:

Guidance Documents NTS TBD-3, ORAUT-OTIB-0006. NTS TBD-3, ORAUT-OTIB-0006.

Frequency 3 documented x-ray exams. 3 documented x-ray exams

Dose Distribution Normal; GSD = 30%. Normal; GSD = 30%.

NA = not applicable or not analyzed. 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

11 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table 2-3. Comparison of Internal Dose Data and Assumptions Used by 

SC&A and NIOSH 

Parameters SC&A NIOSH

Bioassay Internal:

Records/Guidance 

Documents Bioassay records not available. Bioassay records not available.

Environmental Internal:

Records/Guidance 

Documents

NTS TBD-4, TBD-5, OTIB-0005, & 

CADW.

NTS TBD-4, TBD-5, OTIB-0005, & 

CADW.

Dose Determination 

Approach Best-estimate methodology. Best-estimate methodology.

Solubility Type Site default. Site default.

Dose Distribution Constant, with zero uncertainty. Constant, with zero uncertainty.

2.1 OCCUPATIONAL EXTERNAL DOSE CALCULATIONS 

2.1.1 Recorded Photon and Electron Doses 

The DOE files contained monthly badge readings. Most of the recorded readings were zero with 

the only positive reading recorded in [redact]. All recorded shallow doses were zero or 

<LOD/2. 

Comparison of SC&A’s and NIOSH’s Methods and Doses for Recorded Photons 

Both DR methods assumed the EE worked primarily in the NTS [redact]. Therefore, the photon 

energy fraction of 22% 30–250 keV and 78% >250 keV was assumed, as specified in ORAUTTKBS-0008-6, Table 6-13, page 50, for areas associated with routine [redact] operations. Both 

SC&A and NIOSH selected DCFs that reflected Exposure (R) to Organ Dose (HT) values from 

OCAS-IG-001. The urinary bladder was used as the surrogate organ for the prostate (ORAUTOTIB-0005, page 20), and the red bone marrow (RBM) was used as the surrogate organ for the 

thrombocytosis (ORAUT-OTIB-0005, page 38). SC&A and NIOSH used the mode DCF values 

listed in OCAS-IG-001; it did not appear that NIOSH used Monte Carlo-generated DCFs in this 

case.

Using the EE’s dosimetry records and above-cited parameters, SC&A and NIOSH assigned 

photon and electron recorded doses, as shown in Table 2-4. The slightly larger photon doses 

assigned to the prostate and RBM by NIOSH reflects NIOSH’s use of a conservative DCF of 

1.00 when OCAS-IG-001 recommended a DCF of <1.00. In addition, NIOSH used a constant 

distribution for the prostate and RBM doses; therefore, the derived dose was multiplied by an 

uncertainty factor of 1.3 before it was entered into the IREP Input tables. SC&A used the DCFs 

as recommended in OCAS-IG-001, and a normal distribution, with the 30% uncertainty entered 

into Parameter 2 of the IREP Input tables. 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

12 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table 2-4. Comparison of Recorded Photon Doses 

SC&A (rem) NIOSH (rem)

Prostate total recorded photon dose 0.048 0.069

RBM total recorded photon dose 0.035 0.065

Skin total recorded photon dose – 1979* 0.050 0.050

*There was only recorded dose during 1979. 

2.1.2 Missed Photon and Electron Doses 

Missed photon and electron doses were assigned by both SC&A and NIOSH. 

Comparison of SC&A’s and NIOSH’s Methods Used to Assign Missed Dose 

SC&A analyzed the number of actual zeros and potential zeros based on a monthly badge 

exchange cycle using the guidance in OCAS-IG-001, page 16, to arrive at a total of 207 zeros (or 

<LOD/2 values) for photons, and 1 zero (or <LOD/2 value) for electrons; this matched the 

number of zeros used by NIOSH in this case. SC&A and NIOSH used the annual number of 

zeros, the LOD/2 value, the DR parameters as listed above, and the applicable DCFs to 

determine the annual missed photon and electron doses. 

SC&A’s Missed Photon Dose

SC&A used the following methods to derive missed photon dose: 

 DCFs as recommended in OCAS-IG-001 and ORAUT-OTIB-0017. 

 For the skin cancer diagnosed in [redact], SC&A used 6 zeros to derive the missed 

photon dose because the cancer was diagnosed on [redact]. 

 For [redact], SC&A applied the dosimetry limit of detection (LOD) value of 0.040 rem 

for the months of January and February [redact], and the value of 0.030 rem for the 

months of March through December [redact].

NIOSH’s Missed Photon Dose 

NIOSH used the following methods to derive missed photon dose: 

 DCFs as recommended in OCAS-IG-001, or a value of 1.00, whichever was greater. 

 For the skin cancer diagnosed in [redact], NIOSH used the entire year of 12 zeros to 

derive the missed photon dose for the cancer that was diagnosed on [redact].

 For [redact], NIOSH applied the dosimetry LOD value of 0.040 rem for 12 months to 

some organs, and the value of 0.030 rem for 12 months to other organs.

Comparison of SC&A’s and NIOSH’s Missed Photon Doses 

SC&A and NIOSH assigned missed photon and electron doses as shown in Table 2-5. The 

larger missed photon doses assigned by NIOSH were due to the fact that: 

 NIOSH always applied DCF >1.00 for all organs for all photon energies, whereas SC&A 

used the DCFs recommended in OCAS-IG-001. 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

13 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

 NIOSH applied 12 zeros to the [redact] skin cancer that was diagnosed on [redact], 

which was greater than the dose derived by SC&A using 6 zeros. 

 NIOSH applied the larger dosimeter LOD value of 0.040 rem for the entire year of 

[redact] to missed skin doses, whereas SC&A applied the larger dosimeter LOD value 

for only the months of January and February of [redact], and the lower value thereafter,

as recommended in ORAUT-TKBS-0008-6, Table 6-1, page 19. 

 NIOSH applied the smaller dosimeter LOD value of 0.030 rem for the entire year of 

[redact] to prostate and RBM missed doses, whereas SC&A applied the larger dosimeter 

LOD value for the months of January and February of [redact], and the lower value 

thereafter, as recommended in ORAUT-TKBS-0008-6, Table 6-1, page 17. 

Table 2-5. Comparison of Missed Photon and Electron Doses 

SC&A (rem) NIOSH (rem)

Prostate total missed photon dose 3.417 3.730

RBM total missed photon dose 2.483 3.540

Skin ([redact]) total missed photon dose 2.140 2.280

Skin ([redact]–[redact]) total missed photon dose 3.550 3.600

Skin total missed electron dose ([redact]–[redact]) 0.015 0.015

Both DR methods entered missed photon and electron doses into the Interactive RadioEpidemiological Program (IREP) as a lognormal distribution with an uncertainty of 1.520. 

2.1.3 Onsite Ambient Doses 

As per ORAUT-PROC-0060, page 14, external ambient dose should not be applied when the EE 

is assigned recorded and missed doses. Therefore, neither SC&A nor NIOSH assigned external 

ambient dose in this case, since the EE was assigned recorded and missed doses for all years of 

employment. 

2.1.4 Occupational Medical Doses 

Both DR methods: 

 Calculated an occupational medical dose from diagnostic x-ray procedures required as a 

condition of employment. 

 Used the number and type of x-ray exams as provided in the EE’s DOE files. 

 Assigned doses for 3 posterior-anterior (PA) view and 2 lateral (LAT) view x-ray exams. 

 Used doses recommended in Tables 3-3 and 3-5 of ORAUT-TKBS-0008-3 for PA and 

LAT views.

 Assigned LAT view doses for x-ray exams performed after 1972, as per Table 3-5 of 

ORAUT-TKBS-0008-3.
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

14 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Comparison of SC&A’s and NIOSH’s Medical X-ray Assigned Doses 

SC&A and NIOSH assigned identical x-ray doses. Both DR methods used the pre-calculated 

skin dose table (Table 3-5 in ORAUT-TKBS-0008-3) for determining the various skin doses. 

Using data from this table provides for greater consistency in DR results as compared to 

manually calculating skin doses using the entrance skin dose (ENSD) and applying various 

modification factors for a particular skin location outside the primary beam, as is required if 

using values listed in the tables in Attachment C of ORAUT-PROC-0061. There is, however, 

still some subjectivity in the location selected for a given cancer site when using Table 3-5 of 

ORAUT-TKBS-0008-3. For example, the [redact] or scalp is not listed in Table 3-5; therefore, 

either the left side of the face or the eye/brain could be used as a possible surrogate organ for the 

[redact], and the right/left temple or the back of the neck are possible surrogate organs for the 

scalp. This can lead to some differences in the assigned dose for various locations. However, 

the x-ray doses to locations outside the primary beam are relatively small and the selection of 

surrogate organs generally does not impact the assigned dose significantly. 

Table 2-6 shows a comparison of the occupational medical doses calculated by the two DR 

methods. 

Table 2-6. Comparison of Occupational Medical Doses 

SC&A (rem) NIOSH (rem)

Skin-[redact] [redact] 0.133 0.133

Skin-scalp [redact] 0.042 0.042

Prostate [redact] 0.003 0.003

Skin-neck (2) [redact] 0.069 0.069

Skin-[redact] [redact] 0.031 0.032

RBM [redact] 0.021 0.021

Skin-[redact] [redact] 0.032 0.032

Both methods entered annual doses into IREP as a normal distribution with an uncertainty of 

30%. 

2.2 OCCUPATIONAL INTERNAL DOSES 

There were no recorded bioassay results for this EE in the DOE records. According to the 

information provided in the Site Profile for the NTS SEC (ORAUT-TKBS-0008-5, page 12),

internal radiation doses at NTS cannot be reconstructed prior to 1993. Therefore, because no 

bioassay data are available for the EE, no techniques can be employed to derive an estimate of 

internal dose, except for internal dose from the intake of ambient air activity. 

2.2.1 Internal Environmental Dose 

Both SC&A and NIOSH used the NTS site default radionuclides and associated intakes by 

inhalation as a function of year (ORAUT-TKBS-0008-4, Table A-7, page 67) and the maximum 

intake values for ingestion (ORAUT-TKBS-0008-4, Table A-12, page 77) for the years of 

employment in the chronic annual dose workbook (CADW) to derive a best estimate of the 

annual doses to the eight cancers. As per ORAUT-OTIB-0005 guidelines, SC&A used all male 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

15 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

genitalia as the surrogate organ for the prostate (page 20); the bone and also lymphoma & 

multiple myeloma for the thrombocytosis (page 38); and the corresponding type of skin cancer 

(i.e., malignant melanoma, BCC, or SCC) for each skin cancer site in the CADW. This 

evaluation included chronic inhalation and ingestion of NTS environmental Am-241, Co-60, 

Cs-137, Eu-152, Eu-154, Eu-155, Pu-238, Pu-239, Pu-240, and Sr-90 for full years from 1963 to 

1982 (1963 was the first year that environmental data were available). 

Essential thrombocytosis (ICD-9 Code 238.71) 

According to ORAUT-OTIB-0005, page 38, for the essential thrombocytosis cancer (ICD-9 

Code 238.71), both the bone and the lymphoma & multiple myeloma IREP models should be 

run, and the one that produces the greater dose used in the DR. Both SC&A and NIOSH found 

that the bone IREP model provided for the greater dose and used its associated annual doses in 

the IREP Input table. 

Type SS Plutonium 

The EE’s cancer sites involved systemic organs. ORAUT-OTIB-0049, Table 4-8, page 17, 

recommends when assigning plutonium doses using measured air concentrations to systemic 

organs that no Type SS adjustment be made, because more soluble Types M or S plutonium 

provide for greater doses to these organs. 

Table 2-7 shows a comparison of the internal doses calculated by the two DR methods. 

 

Table 2-7. Comparison of Internal Environmental Doses 

SC&A (rem) NIOSH (rem)

Skin-[redact] [redact] 0.003 0.003

Skin-scalp [redact] 0.009 0.009

Prostate [redact] 0.013 0.013

Skin-neck (2) [redact] 0.009 0.009

Skin-[redact] [redact] 0.010 0.010

RBM [redact] 0.234 0.234

Skin-[redact] [redact] 0.011 0.011

Both methods entered annual doses into IREP as a constant with zero uncertainty. 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

16 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

3.0 SUMMARY CONCLUSIONS 

Total external and internal doses and resultant POCs calculated by NIOSH and SC&A in behalf 

of Case #[Redact] are presented in Table 3-1 for comparison. 

Table 3-1. Comparison of SC&A’s and NIOSH’s Total External and Internal Dose

Estimates for the 8 Cancers 

SC&A (rem) POC NIOSH (rem) POC

Skin-[redact] [redact] 2.256 4.31% 2.396 4.31%

Skin-scalp [redact] 3.666 12.66% 3.716 10.88%

Prostate [redact] 3.480 3.45% 3.814 3.83%

Skin-neck [redact] (1.73.41) 3.694 10.52% 3.744 11.24%

Skin-neck [redact] (1.73.4) 3.694 10.67% 3.744 11.16%

Skin-[redact] [redact] 3.656 2.29% 3.708 2.32%

RBM [redact] 2.773 3.55% 3.859 4.74%

Skin-[redact] [redact] 3.658 2.27% 3.708 2.23%

Combined POC 40.59% 41.17%

As shown in Table 3-1, SC&A’s and NIOSH’s dose estimates and resulting POCs are in close 

agreement. The main difference was in external doses and resulted due to NIOSH applying 

values all >1.00 for DCFs, whereas SC&A used the mode values as listed in OCAS-IG-001.

A more detailed discussion of variables that contributed to key differences in dose assignments is 

presented below. 

 Dose Reconstruction Methodology 

– SC&A employed a best-estimate approach to dose reconstruction throughout. 

– NIOSH employed best-estimate and some over-estimate approaches to external 

doses, and a best-estimate approach to internal dose reconstruction. 

 Dose Conversion Factors 

 – SC&A applied DCFs as recommended in ORAUT-OTIB-0017 and OCAS-IG-001.

 – NIOSH applied DCFs using ORAUT-OTIB-0017 and OCAS-IG-001 data; however, 

when any of the DCFs were <1.0, NIOSH used a DCF of 1.00 as an over-estimating 

methodology.

–This difference in methodology resulted in NIOSH assigning larger recorded and 

missed external doses in some instances. 

 Dose Distribution 

– SC&A used the following dose distributions: 

 Recorded photon dose; normal distribution with 30% uncertainty 

 Missed photon dose; lognormal distribution with 1.50 GSD 

 Medical x-ray dose; normal distribution with 30% uncertainty 

 Internal environmental dose; constant with no uncertainty. 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

17 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

– NIOSH used the following dose distributions: 

 Recorded photon skin dose; constant with no uncertainty 

 Recorded prostate and RBM photon doses; constant (with dose multiplied 

by a 1.3 uncertainty factor) with no uncertainty in the distribution 

 Missed photon dose; lognormal distribution with a 1.50 GSD 

 Medical x-ray dose; normal distribution with a 30% uncertainty 

 Internal environmental dose; constant with no uncertainty. 

– The difference in distributions for recorded doses resulted in NIOSH deriving 

greater recorded doses than SC&A in some instances. 

 Assignment of Missed External Dose 

– Both SC&A and NIOSH derived the same number of missed photon and electron 

doses. 

– SC&A applied the dosimeter LOD value of 0.040 rem for the months of January 

and February of [redact], and the lower value of 0.030 rem thereafter; as 

recommended in ORAUT-TKBS-0008-6, Table 6-1, page 19. 

– NIOSH applied the larger dosimeter LOD value of 0.040 rem for the entire year 

of [redact] to missed skin dose, but the lower LOD value of 0.030 rem to the 

prostate and RBM for the entire year of [redact]. 

– This created some differences in the derived missed photon doses for the year 

[redact], and the resulting total doses; this varied depending on the organ. 

 Assignment of [Redact] Skin Cancer Missed Photon Dose

– SC&A used 6 zeros for missed photon dose for the [redact], skin cancer.

– NIOSH used 12 zeros for missed photon dose for the [redact], skin cancer.

– This difference in methodology resulted in NIOSH assigning a greater missed 

photon dose for the [redact] skin cancer, as compared to SC&A’s dose value. 

 Assignment of Onsite Ambient Dose 

 – Neither SC&A nor NIOSH assigned onsite external ambient dose because the EE was 

assigned recorded or missed doses for the entire employment period at NTS. 

 Assignment of Occupational Medical X-ray Dose 

– Both SC&A and NIOSH used the number and view of recorded exams in the 

DOE files for this EE to assign medical x-ray doses. 

– Both SC&A and NIOSH used the dose tables in NTS ORAUT-TKBS-0008-3 to 

assign doses. 

– Medical dose assigned by SC&A and NIOSH for the various cancers closely 

matched. 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

18 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

 Assignment of Internal Dose 

– Both SC&A and NIOSH used the best-estimate approach to assign environmental 

intakes/doses. 

– Both SC&A and NIOSH used the NTS environmental default intakes to assign 

environmental intakes/doses. 

– Internal doses assigned by SC&A and NIOSH for the various cancers were 

identical. 
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

19 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

4.0 REFERENCES 

ICRP (International Commission on Radiological Protection) 1990. Recommendations of the 

International Commission on Radiological Protection, Publication 60, Pergamon Press, Oxford, 

England. 

OCAS-IG-001. 2007. External Dose Reconstruction Implementation Guideline, Rev. 3, 

National Institute for Occupational Safety and Health, Office of Compensation Analysis and 

Support, Cincinnati, Ohio. November 21, 2007. 

ORAUT-OTIB-0005. 2011. Technical Information Bulletin: Internal Dosimetry Organ, 

External Dosimetry Organ, and IREP Model Selection by ICD-9 Code, Rev. 04, Oak Ridge 

Associated Universities Team, Cincinnati, Ohio. April 18, 2011. 

ORAUT-OTIB-0006. 2011. Technical Information Bulletin: Dose Reconstruction from 

Occupational Medical X-Ray Procedures, Rev. 04. Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. June 20, 2011. 

ORAUT-OTIB-0017. 2009. Technical Information Bulletin: Interpretation of Dosimetry Data 

for Assignment of Shallow Dose, Rev. 02-A, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. July 20, 2009. 

ORAUT-OTIB-0049. 2010. Technical Information Bulletin: Estimating Doses for Plutonium 

Strongly Retained in the Lung, Rev. 01 PC-2, Oak Ridge Associated Universities, Cincinnati, 

Ohio. November 29, 2010. 

ORAUT-PROC-0006. 2006. Occupational Onsite Ambient Dose Reconstruction for DOE Sites, 

Rev. 01. Oak Ridge Associated Universities, Cincinnati, Ohio. June 28, 2006.

ORAUT-PROC-0060. 2006. Occupational On-Site Ambient Dose Reconstruction for DOE 

Sites, Rev. 01, Oak Ridge Associated Universities Team, Cincinnati, Ohio. June 28, 2006. 

ORAUT-PROC-0061. 2010. Occupational X-Ray Dose Reconstruction for DOE Sites, Rev. 03, 

Oak Ridge Associated Universities Team, Cincinnati, Ohio. March 3, 2010. 

ORAUT-TKBS-0008-3. 2012. Technical Basis Document for the NTS – Occupational Medical 

Dose, Rev. 02, Oak Ridge Associated Universities Team, Cincinnati, Ohio. November 26, 2012.

ORAUT-TKBS-0008-4. 2012. Technical Basis Document for the Nevada Test Site –

Occupational Environmental Dose, Rev. 03, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. August 24, 2012.

ORAUT-TKBS-0008-5. 2012. Technical Basis Document for the Nevada Test Site –

Occupational Internal Dose, Rev. 03, Oak Ridge Associated Universities Team, Cincinnati, 

Ohio. August 17, 2012.
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

20 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

ORAUT-TKBS-0008-6. 2012. Technical Basis Document for the Nevada Test Site –

Occupational External Dosimetry, Rev. 03, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. November 9, 2012.

SC&A 2015. SC&A’s Blind Dose Reconstruction of Case #[Redacted] from the Nevada Test 

Site, SCA-TR-BDR2015-CN[Redact], Rev. 0, SC&A, Inc., Vienna, Virginia. February 12, 

2015.
Effective Date:

April 13, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-DRC2015-CN[Redact]

Page No.

21 of 21

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

ADDENDUM A: SC&A’S BLIND DR REPORT FOR CASE #[REDACT]
DRAFT 

REPORT TO THE ADVISORY BOARD 

ON RADIATION AND WORKER HEALTH

National Institute of Occupational Safety and Health 

BLIND DOSE RECONSTRUCTION OF CASE #[REDACT]

FROM THE NEVADA TEST SITE

Contract No. 211-2014-58081 

SCA-TR-BDR2015-CN[Redact]

Prepared by 

S. Cohen & Associates 

1608 Spring Hill Road, Suite 400 

Vienna, Virginia 22182 

February 2015

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

2 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

S. Cohen & Associates:

Technical Support for the Advisory Board on

Radiation & Worker Health Review of

NIOSH Dose Reconstruction Program

Document No. 

SCA-TR-BDR2015-CN[Redact]

Effective Date: 

Draft – February 12, 2015

Revision No. 

0 (Draft)

BLIND DOSE RECONSTRUCTION 

OF CASE #[REDACT] FROM THE NEVADA TEST 

SITE

Page 2 of 43

Task Manager:

________________________ Date: ___________

Douglas Farver, MS

Supersedes:

N/A

Project Manager:

________________________ Date: ___________

John Stiver, MS, CHP

Reviewer:

 Rose Gogliotti

 Kathleen Behling

 Douglas Farver

 John Stiver

Record of Revisions

Revision 

Number Effective Date Description of Revision

0 (Draft) 2/12/2015 Initial issued.
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

3 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

TABLE OF CONTENTS 

Abbreviations and Acronyms ......................................................................................................... 4

1.0 Summary Background Information .................................................................................... 5

1.1 SC&A’s Blind DR Approach ................................................................................. 5

2.0 External Doses .................................................................................................................... 7

2.1 Recorded Photon Doses .......................................................................................... 7

2.2 Missed Photon/Electron Doses ............................................................................... 8

2.3 Neutron Dose .......................................................................................................... 8

2.4 Occupational Medical Dose .................................................................................... 8

2.5 Onsite Ambient Dose .............................................................................................. 9

3.0 Internal Doses ................................................................................................................... 10

3.1 Internal Environmental Intakes/Doses .................................................................. 10

4.0 CATI Report and Radiological Incidents ......................................................................... 11

5.0 Summary Conclusions ...................................................................................................... 12

References ..................................................................................................................................... 13

Appendix A-1: IREP Input – [Redact] [Redact] #1 ..................................................................... 14

Appendix A-2: IREP Input – [Redact] Scalp #2 .......................................................................... 16

Appendix A-3: IREP Input – [Redact] Prostate #3 ...................................................................... 20

Appendix A-4: IREP Input – [Redact] [Redact] Neck #4 ........................................................... 24

Appendix A-5: IREP Input – [Redact] [Redact] Neck #5 ........................................................... 28

Appendix A-6: IREP Input – [Redact] [Redact] #6 ..................................................................... 32

Appendix A-7: IREP Input – [Redact] Thrombocytosis #7 ......................................................... 36

Appendix A-8: IREP Input – [Redact] [Redact] #8 ..................................................................... 40
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

4 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

ABBREVIATIONS AND ACRONYMS 

AP anterior-posterior 

BCC basil cell carcinoma 

CADW chronic annual dose workbook 

CATI Computer-Assisted Telephone Interview 

D.D. deep dose 

DCF dose conversion factors 

DOE (U.S.) Department of Energy 

DOL (U.S.) Department of Labor 

DR dose reconstruction 

EE energy employee 

ICD International Classification of Diseases 

IREP Interactive RadioEpidemiological Program 

keV kilo electron volt; 1,000 electron volts 

LAT lateral 

LOD limit of detection 

NIOSH National Institute for Occupational Safety and Health 

NTS Nevada Test Site 

PA posterior-anterior 

POC probability of causation 

RBM red bone marrow 

rem Roentgen equivalent man 

SC&A S. Cohen and Associates (SC&A, Inc.) 

SCC squamous cell carcinoma 

SEC Special Exposure Cohort 

TBD technical basis document 
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

5 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

1.0 SUMMARY BACKGROUND INFORMATION 

This report presents the results of an independent blind dose reconstruction (DR) performed by 

SC&A for an energy employee (EE) who worked as a [redact] at the Nevada Test Site (NTS) 

during the following periods: 

 [redact]–[redact]

 [redact]–[redact]

 [redact]–[redact]

 [redact]–[redact]

The EE was diagnosed with eight cancers during the period [redact]–[redact], summarized in 

Table 1:

Table 1. Summary of Cancers 

Cancer Cancer Site ICD-9 Code Year

#1 Malignant melanoma [redact] 172.5 [redact]

#2 BCC [redact] scalp 173.41 [redact]

#3 Prostate 185 [redact]

#4 BCC [redact] neck 173.41 [redact]

#5 Melanoma [redact] neck 172.4 [redact]

#6 SCC in-situ [redact] 232.32 [redact]

#7 Essential thrombocytosis 238.71 [redact]

#8 SCC in-situ [redact] 232.3 [redact]

BCC = Basil cell carcinoma, SCC = Squamous cell carcinoma 

This was a partial DR, because not all internal doses could be assigned prior to 1993, as per the 

NTS Special Exposure Cohort (SEC), which is discussed in ORAUT-TKBS-0008-5, page 13. 

The EE was employed at NTS during the SEC period; however, since at least one of the cancers 

was a non-presumptive cancer, a DR was required. 

According to Department of Labor (DOL) files and the Computer-Assisted Telephone Interview 

(CATI) report, the EE was a [redact] at NTS. The EE worked in the [redact] as needed. The 

EE was monitored for external photon exposure during most of the employment periods at NTS, 

but was not bioassayed. 

1.1 SC&A’S BLIND DR APPROACH 

SC&A reviewed all of the DOE records provided on behalf of this employee and the NIOSH 

procedures relevant to this case, which included the Technical Basis Document (TBD) for the 

NTS (issued as six separate documents numbered ORAUT-TKBS-0008-1 through ORAUTTKBS-0008-6), ORAUT-OTIB-0005 for surrogate organs, OCAS-IG-001 for dose conversion 

factors (DCFs), and ORAUT-OTIB-0017 for skin doses. Using the guidance provided in these 

documents, along with the EE’s dosimetry records, SC&A calculated reasonable, claimantfavorable annual organ doses for each of the eight cancer sites. Table 2 provides a summary of 

the total doses assigned to each cancer site. Appendices A-1 through A-8 provide a list of 

SC&A’s assigned annual organ dose, and also includes the Interactive RadioEpidemiological 
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

6 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Program (IREP) input parameters, such as energy range, distribution type, and uncertainty for 

each year. 

Table 2. Summary of SC&A-Derived External/Internal Dose Estimates 

#1 -

[redact]

[redact]

IREP entry

Dose

(rem)

#2 - Scalp

[redact]

IREP 

entry

Dose

(rem)

#3 -

Prostate

[redact]

IREP entry

Dose

(rem)

#4 & #5 - Neck (2)

[redact]

IREP entry

Dose

(rem)

External Dose (Occupational)

 ▪ Recorded Dose:

 30–250 keV Photons NA – 1 0.011 1 0.014 1 0.011

 >250 keV Photons NA – 2 0.039 2 0.034 2 0.039

 ▪ Missed Dose:

 >15 keV Electrons NA – 3 0.015 NA – 3 0.015

 30–250 keV Photons 1–12 2.140 4–23 3.550 3–22 0.972 4–23 3.550

 >250 keV Photons NA – NA – 23–42 2.445 NA –

 ▪ Occupational Medical 

Dose:

 30–250 keV Photons 13–15 0.113 24–28 0.042 43–47 0.003 24–28 0.069

Internal Dose, Environmental:

 Alpha 16–27 0.001 29–68 0.006 48–89 0.006 29–71 0.006

 >250 keV Photons 28–39 0.001 69–110 0.001 90–131 0.004 72–114 0.001

 >15 keV Electrons 40–51 0.001 111–151 0.002 132–173 0.003 115–157 0.002

Total 2.256 3.666 3.480 3.694

Cancer POC 4.31% 12.66% 3.45% 10.52%

#6 - [redact]

[redact]

IREP entry

Dose

(rem)

#7 -

Thrombocytosis

[redact]

IREP entry

Dose

(rem)

#8 - [redact]

[redact]

IREP entry

Dose

(rem)

External Dose (Occupational)

 ▪ Recorded Dose:

 30–250 keV Photons 1 0.011 1 0.007 1 0.011

 >250 keV Photons 2 0.039 2 0.028 2 0.039

 ▪ Missed Dose:

 >15 keV Electrons 3 0.015 NA – 3 0.015

 30–250 keV Photons 4–23 3.550 3–22 0.489 4–23 3.550

 >250 keV Photons NA – 23–42 1.994 NA –

 ▪ Occupational Medical Dose:

 30–250 keV Photons 24–28 0.031 43–47 0.021 24–28 0.032

Internal Dose, Environmental:

 Alpha 29–71 0.007 48–96 0.208 29–71 0.007

 >250 keV Photons 72–114 0.001 97–145 0.003 72–114 0.001

 >15 keV Electrons 115–157 0.002 146–194 0.023 115–157 0.002

Total 3.656 2.773 3.658

Cancer POC 2.29% 3.55% 2.27%

SC&A determined the probability of causation (POC) for this case using the annual doses as 

input into the NIOSH POC program. The doses shown in Table 2 produced a total POC of 

40.59%.
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

7 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

2.0 EXTERNAL DOSES 

To perform this DR, SC&A analyzed the Department of Energy DOE files containing the 

monthly badge readings. Most of the recorded readings were zero, with only one positive 

reading recorded in [redact].

SC&A used the DR parameters as recommended in ORAUT-TKBS-0008-6, which consisted of 

an energy range of 22% 30–250 keV photons, 78% >250 keV photons (Table 6-13, page 50) 

associated with routine [redact] operations, and a limit of detection (LOD) value of 0.040 rem for 

[redact] through [redact] and 0.030 rem for [redact] through [redact] (Table 6-1, page 17). 

Exposure (as opposed to deep) DCFs were used, as per ORAUT-TKBS-0008-6, pages 19–20. 

The urinary bladder was used as the surrogate organ for the prostate (ORAUT-OTIB-0005, page 

20), and the red bone marrow (RBM) was used as the surrogate organ for the thrombocytosis 

(ORAUT-OTIB-0005, page 38). SC&A used DCFs as recommended in OCAS-IG-001 [for 

anterior-posterior (AP) geometry], which consisted of a prostate 30–250 keV photon DCF of 

1.244, a >250 keV photon DCF of 0.883 (page 46), an RBM 30–250 keV photon DCF of 0.626, 

and a >250 keV photon DCF of 0.720 (page 47). A skin DCF of 1.00 was used, as per ORAUTOTIB-0017, page 6. 

2.1 RECORDED PHOTON DOSES 

SC&A used the [redact] recorded photon dose value of 0.050 rem to assign measured photon 

doses using the parameters previously described. There were no electron doses recorded 

>LOD/2.

Example of [redact] recorded photon dose calculations – SC&A calculated the [redact] photon 

dose to the prostate as follows:

Records show that for the month of [redact], the EE received a deep dose of 0.050 rem. The 

photon dose was assumed to be 22% 30–250 keV and 78% >250 keV. Prostate DCFs of 

1.244 for 30–250 keV photons and 0.883 for >250 keV photons were applied. 

30–250 keV photon dose = D.D. × DCF × Energy f. 

= 0.050 × 1.244 × 0.22 

= 0.014 rem 

 >250 keV photon dose = D.D. × DCF × Energy f. 

= 0.050 × 0.883 × 0.78 

= 0.034 rem 

SC&A’s calculated [redact] 30–250 keV and >250 keV doses are shown in entries #1 and #2, 

respectively, of Appendix A-3 for the prostate.

The recorded photon doses were entered into the IREP as a normal distribution with a 30% 

uncertainty (ORAUT-TKBS-0008-6, page 91, was the best guidance available). SC&A assigned 
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

8 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

recorded doses to the eight cancer sites in entries #1–#2 of the IREP Input tables; as summarized 

in Table 2 above, and detailed in Appendices A-2 through A-8. 

2.2 MISSED PHOTON/ELECTRON DOSES 

SC&A analyzed the number of physical zeros based on a monthly badge exchange cycle and 

arrived at a total of 207 zeros, or <LOD/2 values, for photons. SC&A used the annual number of 

zeros, the LOD/2 value, the DR parameters as listed above, and the applicable DCFs to 

determine the annual missed photon and electron doses. SC&A noted that during the year 

[redact], the LOD value changed from 0.040 rem during January and February to 0.030 rem for 

March through December. SC&A used the appropriate LOD values for each time period in 

assigning dose in the IREP tables. 

Example of [redact] missed photon dose calculations – SC&A calculated the missed [redact]

photon dose to the prostate as follows:

Records show that for the 12 months of [redact], the EE had received a deep dose of 

0.050 rem; plus, 11 zeros were recorded. The photon dose was assumed to be 22% 30–

250 keV and 78% >250 keV. Prostate DCFs of 1.244 for 30–250 keV photons and 0.883 for 

>250 keV photons were applied. The LOD for [redact] was 0.030 rem.

Missed Photon Dose (30–250 keV) = (# zeros × LOD/2) × DCF × Energy f. 

 = (11 × 0.015 rem) × 1.244 × 0.22 

 = 0.045 rem 

Missed Photon Dose (>250 keV) = (# zeros × LOD/2) × DCF × Energy f. 

= (11 × 0.015 rem) × 0.883 × 0.78

 = 0.114 rem 

The photon missed doses were entered into IREP as a lognormal distribution with an uncertainty 

of 1.520. The missed photon doses were assigned in the IREP Input tables, as summarized in 

Table 2 above, and detailed in Appendices A-1 through A-8. Missed photon dose to the skin 

cancer sites were assigned as 100% 30–250 keV photons, as recommended in ORAUT-OTIB0017, page 18.

2.3 NEUTRON DOSE 

SC&A found that, as a [redact], the EE most likely would not have been exposed to significant 

neutron doses; therefore, as per ORAUT-TKBS-0008-6, page 43, no neutron dose was assigned 

in this case.

2.4 OCCUPATIONAL MEDICAL DOSE 

Records 

The DOE records show that the EE received a routine x-ray exam in [redact], [redact], and 

[redact] (a [redact] exam was performed in [redact], but was labeled as non-occupational, and 
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

9 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

not included as per recommendations in ORAUT-TKBS-0008-3, page 10). Posterior-anterior 

(PA) views were assumed for all exams, plus lateral (LAT) views for those taken after [redact], 

as per ORAUT-TKBS-0008-3, Table 3-1, page 7. 

SC&A used the appropriate prostate and RBM dose values recommended in Table 3-3, page 11, 

of ORAUT-TKBS-0008-3 as a function of the year the exam was performed, and the appropriate 

skin doses from Table 3-5, page 13, for five of the six skin cancer sites. The eye/brain dose was 

used as a surrogate for the skin of the forehead, because of its physical location, to assign 

occupational medical x-ray doses in the IREP Input tables. A summary of the locations used for 

the cancer sites is listed below: 

 #1 [redact] – [redact]

 #2 scalp – Right side of head 

 #3 prostate – Urinary bladder/prostate 

 #4 [redact] neck – Back of neck

 #5 [redact] neck – Back of neck

 #6 [redact] – Eye/brain

 #7 thrombocytosis – Bone marrow (male) 

 #8 [redact] – Left side of face

The doses assigned are summarized in Table 2 above, and detailed in Appendices A-1 through 

A-8. The annual occupational medical dose values were entered into the IREP as a normal 

distribution with 30% uncertainty and a photon energy range of 30–250 keV.

2.5 ONSITE AMBIENT DOSE

As per ORAUT-PROC-0060, Attachment A, page 14, external ambient dose should not be 

applied when the EE is assigned recorded (and/or missed) dose. Therefore, no external ambient 

dose was assigned in this case since the EE was assigned recorded and/or missed doses for all 

years of employment.
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

10 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

3.0 INTERNAL DOSES 

There were no bioassay records in the EE’s DOE files. Therefore, according to the NTS SEC, 

internal dose could not be reconstructed, except for environmental. 

3.1 INTERNAL ENVIRONMENTAL INTAKES/DOSES 

Intake and Doses 

SC&A used the NTS default environmental intakes in the chronic annual dose workbook 

(CADW), located in the DR Tools folder, to derive the intakes and corresponding annual doses 

for each of the eight cancers. As per ORAUT-OTIB-0005 guidelines, SC&A used all male 

genitalia as the surrogate organ for the prostate (page 20); the bone and also lymphoma & 

multiple myeloma for the thrombocytosis (page 38); and the corresponding type of skin cancer 

(i.e., malignant melanoma, BCC, or SCC) for each skin cancer site in the CADW. The doses 

consisted of contributions from alphas, >250 keV photons, and >15 keV electron emitters. 

IREP Tables 

The annual doses from the CADWs were entered into the IREP Input tables (one IREP table for 

each cancer, for a total of eight IREP tables) up through the date of diagnosis for each of the 

cancer sites. The annual dose values were entered into the IREP tables with a constant 

distribution and an uncertainty value of 0.000.

For the thrombocytosis cancer, two IREP input tables were created, one using the bone and the 

other using lymphoma & multiple myeloma as the IREP model, as recommended in ORAUTOTIB-0005, page 38. Both of these IREP tables were analyzed using the POC program and 

found to produce the same POC in this case.
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

11 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

4.0 CATI REPORT AND RADIOLOGICAL INCIDENTS 

SC&A reviewed the DOE records in behalf of Case #[redact] and the CATI report (which was 

provided by the EE) to determine if the EE was involved in any radiological incidents. The 

CATI did not indicate any known radiological accidents or incidents. The EE did have concerns 

that the drinking water in Area 3 may have been contaminated; however, as outlined in the NTS 

SEC, no further internal dose assignments can be made. Additionally, the EE indicated that in 

the late [redact]s or early [redact]s, the EE was involved in work that required that the workers 

spend only a short time in an area because of heavily-radiated material. It is not known if this 

was because of internal or external radiation exposure potential; however, further internal doses 

cannot be reconstructed, and the EE was monitored for external exposures during this time and 

those data were used in the external dose section of this DR.

SC&A did not find any further documentation of radiological incidents that would impact the 

radiation doses assigned in this case.
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

12 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

5.0 SUMMARY CONCLUSIONS 

This partial DR used best-estimate methods to obtain reasonable external and internal dose 

assignments. 

The total POC for the eight cancers was calculated using the NIOSH-Interactive RadioEpidemiological Program (v.5.7.1) and was determined to be 40.59%.
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

13 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

REFERENCES 

OCAS-IG-001. 2007. External Dose Reconstruction Implementation Guideline, Rev. 3, 

National Institute for Occupational Safety and Health, Office of Compensation Analysis and 

Support, Cincinnati, Ohio. November 21, 2007. 

ORAUT-OTIB-0005. 2011. Technical Information Bulletin: Internal Dosimetry Organ, 

External Dosimetry Organ, and IREP Model Selection by ICD-9 Code, Rev. 04, Oak Ridge 

Associated Universities Team, Cincinnati, Ohio. April 18, 2011. 

ORAUT-OTIB-0017. 2009. Technical Information Bulletin: Interpretation of Dosimetry Data 

for Assignment of Shallow Dose, Rev. 02-A, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. July 20, 2009. 

ORAUT-PROC-0060. 2006. Occupational On-Site Ambient Dose Reconstruction for DOE 

Sites, Rev. 01, Oak Ridge Associated Universities Team, Cincinnati, Ohio. June 28, 2006. 

ORAUT-TKBS-0008-3. 2012. Technical Basis Document for the NTS – Occupational Medical 

Dose, Rev. 02, Oak Ridge Associated Universities Team, Cincinnati, Ohio. November 26, 2012.

ORAUT-TKBS-0008-5. 2012. Technical Basis Document for the Nevada Test Site –

Occupational Internal Dose, Rev. 03, Oak Ridge Associated Universities Team, Cincinnati, 

Ohio. August 17, 2012.

ORAUT-TKBS-0008-6. 2012. Technical Basis Document for the Nevada Test Site –

Occupational External Dosimetry, Rev. 03, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. November 9, 2012.
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

14 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

APPENDIX A-1: IREP INPUT – [REDACT] [REDACT] #1

CLAIMANT CANCER DIAGNOSES

Primary Cancer 

#1

Primary Cancer 

#2

Primary Cancer 

#3

Secondary 

Cancer #1

Secondary 

Cancer #2

Secondary 

Cancer #3

Cancer Type

Malignant 

Melanoma –

[redact] N/A N/A N/A N/A N/A

Date of Diagnosis N/A N/A N/A N/A N/A N/A

EXPOSURE INFORMATION

Number of exposures

51

Exposure # Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redact] acute photons E=30-250keV Lognormal 0.325 1.520 0.000

2 [redact] acute photons E=30-250keV Lognormal 0.050 1.520 0.000

3 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

4 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

5 [redact] acute photons E=30-250keV Lognormal 0.220 1.520 0.000

6 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

7 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

8 [redact] acute photons E=30-250keV Lognormal 0.160 1.520 0.000

9 [redact] acute photons E=30-250keV Lognormal 0.190 1.520 0.000

10 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

11 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

12 [redact] acute photons E=30-250keV Lognormal 0.090 1.520 0.000

13 [redact] acute photons E=30-250keV Normal 3.01E-02 0.009 0.000

14 [redact] acute photons E=30-250keV Normal 5.60E-02 0.017 0.000

15 [redact] acute photons E=30-250keV Normal 2.67E-02 0.008 0.000

16 [redact] chronic alpha Constant 0.000 0.000 0.000

17 [redact] chronic alpha Constant 0.000 0.000 0.000

18 [redact] chronic alpha Constant 0.000 0.000 0.000

19 [redact] chronic alpha Constant 0.000 0.000 0.000

20 [redact] chronic alpha Constant 0.000 0.000 0.000

21 [redact] chronic alpha Constant 0.000 0.000 0.000

22 [redact] chronic alpha Constant 0.000 0.000 0.000

23 [redact] chronic alpha Constant 0.000 0.000 0.000

24 [redact] chronic alpha Constant 0.000 0.000 0.000

25 [redact] chronic alpha Constant 0.000 0.000 0.000

26 [redact] chronic alpha Constant 0.000 0.000 0.000

27 [redact] chronic alpha Constant 0.000 0.000 0.000

28 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

29 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

30 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

31 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

15 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-1: IREP Input – [Redact] [Redact] #1 (continued)

Exposure # Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

32 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

33 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

34 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

35 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

36 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

37 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

38 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

39 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

40 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

41 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

42 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

43 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

44 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

45 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

46 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

47 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

48 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

49 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

50 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

51 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

Note: The following information applies to all 8 IREP Input tables. 

OTHER ADVANCED FEATURES

Sample Size Random Seed

2000 99

User Defined Uncertainty Distribution

Dose Distribution Type Parameter 1 Parameter 2 Parameter 3

Lognormal 1.000 1.000 0.000

SKIN CANCER INPUTS

Ethnic Origin

[redact]
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

16 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

APPENDIX A-2: IREP INPUT – [REDACT] SCALP #2

CLAIMANT CANCER DIAGNOSES

Primary 

Cancer #1

Primary 

Cancer #2

Primary 

Cancer #3

Secondary 

Cancer #1

Secondary 

Cancer #2

Secondary 

Cancer #3

Cancer Type BCC scalp N/A N/A N/A N/A N/A

Date of Diagnosis N/A N/A N/A N/A N/A N/A

EXPOSURE INFORMATION

Number of exposures

151

Exposure # Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redact] acute photons E=30-250keV Normal 0.011 0.003 0.000

2 [redact] acute photons E>250keV Normal 0.039 0.012 0.000

3 [redact] acute electrons E>15keV Lognormal 0.015 1.520 0.000

4 [redact] acute photons E=30-250keV Lognormal 0.325 1.520 0.000

5 [redact] acute photons E=30-250keV Lognormal 0.050 1.520 0.000

6 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

7 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

8 [redact] acute photons E=30-250keV Lognormal 0.220 1.520 0.000

9 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

10 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

11 [redact] acute photons E=30-250keV Lognormal 0.160 1.520 0.000

12 [redact] acute photons E=30-250keV Lognormal 0.190 1.520 0.000

13 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

14 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

15 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

16 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

17 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

18 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

19 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

20 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

21 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

22 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

23 [redact] acute photons E=30-250keV Lognormal 0.105 1.520 0.000

24 [redact] acute photons E=30-250keV Normal 3.00E-03 0.001 0.000

25 [redact] acute photons E=30-250keV Normal 5.60E-03 0.002 0.000

26 [redact] acute photons E=30-250keV Normal 5.60E-03 0.002 0.000

27 [redact] acute photons E=30-250keV Normal 1.40E-02 0.004 0.000

28 [redact] acute photons E=30-250keV Normal 1.40E-02 0.004 0.000

29 [redact] chronic alpha Constant 0.000 0.000 0.000

30 [redact] chronic alpha Constant 0.000 0.000 0.000

31 [redact] chronic alpha Constant 0.000 0.000 0.000

32 [redact] chronic alpha Constant 0.000 0.000 0.000

33 [redact] chronic alpha Constant 0.000 0.000 0.000

34 [redact] chronic alpha Constant 0.000 0.000 0.000

35 [redact] chronic alpha Constant 0.000 0.000 0.000

36 [redact] chronic alpha Constant 0.000 0.000 0.000

37 [redact] chronic alpha Constant 0.000 0.000 0.000

38 [redact] chronic alpha Constant 0.000 0.000 0.000

39 [redact] chronic alpha Constant 0.000 0.000 0.000

40 [redact] chronic alpha Constant 0.000 0.000 0.000

41 [redact] chronic alpha Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

17 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-2: IREP Input – [Redact] Scalp #2 (continued)

Exposure # Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

42 [redact] chronic alpha Constant 0.000 0.000 0.000

43 [redact] chronic alpha Constant 0.000 0.000 0.000

44 [redact] chronic alpha Constant 0.000 0.000 0.000

45 [redact] chronic alpha Constant 0.000 0.000 0.000

46 [redact] chronic alpha Constant 0.000 0.000 0.000

47 [redact] chronic alpha Constant 0.000 0.000 0.000

48 [redact] chronic alpha Constant 0.000 0.000 0.000

49 [redact] chronic alpha Constant 0.000 0.000 0.000

50 [redact] chronic alpha Constant 0.000 0.000 0.000

51 [redact] chronic alpha Constant 0.000 0.000 0.000

52 [redact] chronic alpha Constant 0.000 0.000 0.000

53 [redact] chronic alpha Constant 0.000 0.000 0.000

54 [redact] chronic alpha Constant 0.000 0.000 0.000

55 [redact] chronic alpha Constant 0.000 0.000 0.000

56 [redact] chronic alpha Constant 0.000 0.000 0.000

57 [redact] chronic alpha Constant 0.000 0.000 0.000

58 [redact] chronic alpha Constant 0.000 0.000 0.000

59 [redact] chronic alpha Constant 0.000 0.000 0.000

60 [redact] chronic alpha Constant 0.000 0.000 0.000

61 [redact] chronic alpha Constant 0.000 0.000 0.000

62 [redact] chronic alpha Constant 0.000 0.000 0.000

63 [redact] chronic alpha Constant 0.000 0.000 0.000

64 [redact] chronic alpha Constant 0.000 0.000 0.000

65 [redact] chronic alpha Constant 0.000 0.000 0.000

66 [redact] chronic alpha Constant 0.000 0.000 0.000

67 [redact] chronic alpha Constant 0.000 0.000 0.000

68 [redact] chronic alpha Constant 0.000 0.000 0.000

69 [redact] chronic alpha Constant 0.000 0.000 0.000

70 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

71 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

72 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

73 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

74 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

75 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

76 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

77 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

78 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

79 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

80 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

81 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

82 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

83 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

84 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

85 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

86 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

87 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

88 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

89 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

90 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

91 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

92 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

93 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

18 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-2: IREP Input – [Redact] Scalp #2 (continued)

Exposure # Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

94 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

95 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

96 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

97 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

98 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

99 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

100 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

101 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

102 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

103 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

104 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

105 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

106 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

107 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

108 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

109 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

110 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

111 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

112 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

113 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

114 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

115 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

116 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

117 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

118 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

119 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

120 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

121 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

122 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

123 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

124 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

125 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

126 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

127 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

128 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

129 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

130 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

131 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

132 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

133 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

134 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

135 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

136 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

137 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

138 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

139 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

140 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

141 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

142 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

143 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

144 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

19 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-2: IREP Input – [Redact] Scalp #2 (continued)

Exposure # Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

145 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

146 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

147 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

148 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

149 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

150 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

151 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

20 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

APPENDIX A-3: IREP INPUT – [REDACT] PROSTATE #3

CLAIMANT CANCER DIAGNOSES

Primary Cancer 

#1

Primary Cancer 

#2

Primary Cancer 

#3

Secondary 

Cancer #1

Secondary 

Cancer #2

Secondary 

Cancer #3

Cancer Type Prostate N/A N/A N/A N/A N/A

Date of Diagnosis N/A N/A N/A N/A N/A N/A

EXPOSURE INFORMATION

Number of exposures

173

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redact] acute photons E=30-250keV Normal 0.014 0.004 0.000

2 [redact] acute photons E>250keV Normal 0.034 0.010 0.000

3 [redact] acute photons E=30-250keV Lognormal 0.089 1.520 0.000

4 [redact] acute photons E=30-250keV Lognormal 0.014 1.520 0.000

5 [redact] acute photons E=30-250keV Lognormal 0.007 1.520 0.000

6 [redact] acute photons E=30-250keV Lognormal 0.066 1.520 0.000

7 [redact] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

8 [redact] acute photons E=30-250keV Lognormal 0.066 1.520 0.000

9 [redact] acute photons E=30-250keV Lognormal 0.066 1.520 0.000

10 [redact] acute photons E=30-250keV Lognormal 0.044 1.520 0.000

11 [redact] acute photons E=30-250keV Lognormal 0.052 1.520 0.000

12 [redact] acute photons E=30-250keV Lognormal 0.049 1.520 0.000

13 [redact] acute photons E=30-250keV Lognormal 0.049 1.520 0.000

14 [redact] acute photons E=30-250keV Lognormal 0.049 1.520 0.000

15 [redact] acute photons E=30-250keV Lognormal 0.049 1.520 0.000

16 [redact] acute photons E=30-250keV Lognormal 0.049 1.520 0.000

17 [redact] acute photons E=30-250keV Lognormal 0.049 1.520 0.000

18 [redact] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

19 [redact] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

20 [redact] acute photons E=30-250keV Lognormal 0.049 1.520 0.000

21 [redact] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

22 [redact] acute photons E=30-250keV Lognormal 0.029 1.520 0.000

23 [redact] acute photons E>250keV Lognormal 0.224 1.520 0.000

24 [redact] acute photons E>250keV Lognormal 0.034 1.520 0.000

25 [redact] acute photons E>250keV Lognormal 0.017 1.520 0.000

26 [redact] acute photons E>250keV Lognormal 0.165 1.520 0.000

27 [redact] acute photons E>250keV Lognormal 0.152 1.520 0.000

28 [redact] acute photons E>250keV Lognormal 0.165 1.520 0.000

29 [redact] acute photons E>250keV Lognormal 0.165 1.520 0.000

30 [redact] acute photons E>250keV Lognormal 0.110 1.520 0.000

31 [redact] acute photons E>250keV Lognormal 0.131 1.520 0.000

32 [redact] acute photons E>250keV Lognormal 0.124 1.520 0.000

33 [redact] acute photons E>250keV Lognormal 0.124 1.520 0.000

34 [redact] acute photons E>250keV Lognormal 0.124 1.520 0.000

35 [redact] acute photons E>250keV Lognormal 0.124 1.520 0.000

36 [redact] acute photons E>250keV Lognormal 0.124 1.520 0.000

37 [redact] acute photons E>250keV Lognormal 0.124 1.520 0.000

38 [redact] acute photons E>250keV Lognormal 0.114 1.520 0.000

39 [redact] acute photons E>250keV Lognormal 0.114 1.520 0.000

40 [redact] acute photons E>250keV Lognormal 0.124 1.520 0.000

41 [redact] acute photons E>250keV Lognormal 0.114 1.520 0.000

42 [redact] acute photons E>250keV Lognormal 0.072 1.520 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

21 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-3: IREP Input – [Redact] Prostate #3 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

43 [redact] acute photons E=30-250keV Normal 2.62E-03 0.009 0.000

44 [redact] acute photons E=30-250keV Normal 7.20E-05 0.000 0.000

45 [redact] acute photons E=30-250keV Normal 7.20E-05 0.000 0.000

46 [redact] acute photons E=30-250keV Normal 9.00E-05 0.000 0.000

47 [redact] acute photons E=30-250keV Normal 9.00E-05 0.000 0.000

48 [redact] chronic alpha Constant 0.000 0.000 0.000

49 [redact] chronic alpha Constant 0.000 0.000 0.000

50 [redact] chronic alpha Constant 0.000 0.000 0.000

51 [redact] chronic alpha Constant 0.000 0.000 0.000

52 [redact] chronic alpha Constant 0.000 0.000 0.000

53 [redact] chronic alpha Constant 0.000 0.000 0.000

54 [redact] chronic alpha Constant 0.000 0.000 0.000

55 [redact] chronic alpha Constant 0.000 0.000 0.000

56 [redact] chronic alpha Constant 0.000 0.000 0.000

57 [redact] chronic alpha Constant 0.000 0.000 0.000

58 [redact] chronic alpha Constant 0.000 0.000 0.000

59 [redact] chronic alpha Constant 0.000 0.000 0.000

60 [redact] chronic alpha Constant 0.000 0.000 0.000

61 [redact] chronic alpha Constant 0.000 0.000 0.000

62 [redact] chronic alpha Constant 0.000 0.000 0.000

63 [redact] chronic alpha Constant 0.000 0.000 0.000

64 [redact] chronic alpha Constant 0.000 0.000 0.000

65 [redact] chronic alpha Constant 0.000 0.000 0.000

66 [redact] chronic alpha Constant 0.000 0.000 0.000

67 [redact] chronic alpha Constant 0.000 0.000 0.000

68 [redact] chronic alpha Constant 0.000 0.000 0.000

69 [redact] chronic alpha Constant 0.000 0.000 0.000

70 [redact] chronic alpha Constant 0.000 0.000 0.000

71 [redact] chronic alpha Constant 0.000 0.000 0.000

72 [redact] chronic alpha Constant 0.000 0.000 0.000

73 [redact] chronic alpha Constant 0.000 0.000 0.000

74 [redact] chronic alpha Constant 0.000 0.000 0.000

75 [redact] chronic alpha Constant 0.000 0.000 0.000

76 [redact] chronic alpha Constant 0.000 0.000 0.000

77 [redact] chronic alpha Constant 0.000 0.000 0.000

78 [redact] chronic alpha Constant 0.000 0.000 0.000

79 [redact] chronic alpha Constant 0.000 0.000 0.000

80 [redact] chronic alpha Constant 0.000 0.000 0.000

81 [redact] chronic alpha Constant 0.000 0.000 0.000

82 [redact] chronic alpha Constant 0.000 0.000 0.000

83 [redact] chronic alpha Constant 0.000 0.000 0.000

84 [redact] chronic alpha Constant 0.000 0.000 0.000

85 [redact] chronic alpha Constant 0.000 0.000 0.000

86 [redact] chronic alpha Constant 0.000 0.000 0.000

87 [redact] chronic alpha Constant 0.000 0.000 0.000

88 [redact] chronic alpha Constant 0.000 0.000 0.000

89 [redact] chronic alpha Constant 0.000 0.000 0.000

90 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

91 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

92 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

93 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

94 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

22 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-3: IREP Input – [Redact] Prostate #3 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

95 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

96 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

97 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

98 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

99 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

100 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

101 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

102 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

103 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

104 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

105 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

106 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

107 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

108 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

109 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

110 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

111 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

112 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

113 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

114 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

115 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

116 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

117 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

118 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

119 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

120 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

121 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

122 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

123 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

124 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

125 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

126 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

127 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

128 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

129 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

130 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

131 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

132 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

133 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

134 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

135 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

136 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

137 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

138 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

139 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

140 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

141 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

142 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

143 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

144 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

145 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

146 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

23 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-3: IREP Input – [Redact] Prostate #3 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

147 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

148 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

149 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

150 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

151 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

152 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

153 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

154 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

155 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

156 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

157 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

158 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

159 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

160 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

161 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

162 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

163 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

164 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

165 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

166 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

167 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

168 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

169 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

170 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

171 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

172 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

173 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

24 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

APPENDIX A-4: IREP INPUT – [REDACT] [REDACT] NECK #4

CLAIMANT CANCER DIAGNOSES

Primary Cancer 

#1

Primary Cancer 

#2

Primary Cancer 

#3

Secondary 

Cancer #1

Secondary 

Cancer #2

Secondary 

Cancer #3

Cancer Type

BCC [redact]

neck N/A N/A N/A N/A N/A

Date of Diagnosis N/A N/A N/A N/A N/A N/A

EXPOSURE INFORMATION

Number of exposures

157

Exposure # Exposure

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redact] acute photons E=30-250keV Normal 0.011 0.003 0.000

2 [redact] acute photons E>250keV Normal 0.039 0.012 0.000

3 [redact] acute electrons E>15keV Lognormal 0.015 1.520 0.000

4 [redact] acute photons E=30-250keV Lognormal 0.325 1.520 0.000

5 [redact] acute photons E=30-250keV Lognormal 0.050 1.520 0.000

6 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

7 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

8 [redact] acute photons E=30-250keV Lognormal 0.220 1.520 0.000

9 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

10 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

11 [redact] acute photons E=30-250keV Lognormal 0.160 1.520 0.000

12 [redact] acute photons E=30-250keV Lognormal 0.190 1.520 0.000

13 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

14 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

15 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

16 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

17 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

18 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

19 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

20 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

21 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

22 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

23 [redact] acute photons E=30-250keV Lognormal 0.105 1.520 0.000

24 [redact] acute photons E=30-250keV Normal 3.01E-02 0.009 0.000

25 [redact] acute photons E=30-250keV Normal 5.60E-03 0.002 0.000

26 [redact] acute photons E=30-250keV Normal 5.60E-03 0.002 0.000

27 [redact] acute photons E=30-250keV Normal 1.40E-02 0.004 0.000

28 [redact] acute photons E=30-250keV Normal 1.40E-02 0.004 0.000

29 [redact] chronic alpha Constant 0.000 0.000 0.000

30 [redact] chronic alpha Constant 0.000 0.000 0.000

31 [redact] chronic alpha Constant 0.000 0.000 0.000

32 [redact] chronic alpha Constant 0.000 0.000 0.000

33 [redact] chronic alpha Constant 0.000 0.000 0.000

34 [redact] chronic alpha Constant 0.000 0.000 0.000

35 [redact] chronic alpha Constant 0.000 0.000 0.000

36 [redact] chronic alpha Constant 0.000 0.000 0.000

37 [redact] chronic alpha Constant 0.000 0.000 0.000

38 [redact] chronic alpha Constant 0.000 0.000 0.000

39 [redact] chronic alpha Constant 0.000 0.000 0.000

40 [redact] chronic alpha Constant 0.000 0.000 0.000

41 [redact] chronic alpha Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

25 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-4: IREP Input – [Redact] [Redact] Neck #4 (continued)

Exposure # Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

42 [redact] chronic alpha Constant 0.000 0.000 0.000

43 [redact] chronic alpha Constant 0.000 0.000 0.000

44 [redact] chronic alpha Constant 0.000 0.000 0.000

45 [redact] chronic alpha Constant 0.000 0.000 0.000

46 [redact] chronic alpha Constant 0.000 0.000 0.000

47 [redact] chronic alpha Constant 0.000 0.000 0.000

48 [redact] chronic alpha Constant 0.000 0.000 0.000

49 [redact] chronic alpha Constant 0.000 0.000 0.000

50 [redact] chronic alpha Constant 0.000 0.000 0.000

51 [redact] chronic alpha Constant 0.000 0.000 0.000

52 [redact] chronic alpha Constant 0.000 0.000 0.000

53 [redact] chronic alpha Constant 0.000 0.000 0.000

54 [redact] chronic alpha Constant 0.000 0.000 0.000

55 [redact] chronic alpha Constant 0.000 0.000 0.000

56 [redact] chronic alpha Constant 0.000 0.000 0.000

57 [redact] chronic alpha Constant 0.000 0.000 0.000

58 [redact] chronic alpha Constant 0.000 0.000 0.000

59 [redact] chronic alpha Constant 0.000 0.000 0.000

60 [redact] chronic alpha Constant 0.000 0.000 0.000

61 [redact] chronic alpha Constant 0.000 0.000 0.000

62 [redact] chronic alpha Constant 0.000 0.000 0.000

63 [redact] chronic alpha Constant 0.000 0.000 0.000

64 [redact] chronic alpha Constant 0.000 0.000 0.000

65 [redact] chronic alpha Constant 0.000 0.000 0.000

66 [redact] chronic alpha Constant 0.000 0.000 0.000

67 [redact] chronic alpha Constant 0.000 0.000 0.000

68 [redact] chronic alpha Constant 0.000 0.000 0.000

69 [redact] chronic alpha Constant 0.000 0.000 0.000

70 [redact] chronic alpha Constant 0.000 0.000 0.000

71 [redact] chronic alpha Constant 0.000 0.000 0.000

72 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

73 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

74 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

75 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

76 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

77 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

78 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

79 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

80 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

81 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

82 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

83 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

84 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

85 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

86 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

87 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

88 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

89 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

90 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

91 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

92 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

93 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

26 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-4: IREP Input – [Redact] [Redact] Neck #4 (continued)

Exposure # Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

94 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

95 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

96 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

97 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

98 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

99 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

100 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

101 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

102 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

103 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

104 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

105 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

106 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

107 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

108 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

109 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

110 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

111 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

112 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

113 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

114 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

115 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

116 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

117 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

118 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

119 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

120 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

121 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

122 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

123 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

124 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

125 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

126 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

127 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

128 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

129 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

130 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

131 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

132 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

133 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

134 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

135 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

136 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

137 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

138 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

139 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

140 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

141 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

142 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

143 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

144 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

145 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

27 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-4: IREP Input – [Redact] [Redact] Neck #4 (continued)

Exposure # Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

146 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

147 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

148 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

149 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

150 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

151 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

152 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

153 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

154 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

155 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

156 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

157 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

28 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

APPENDIX A-5: IREP INPUT – [REDACT] [REDACT] NECK #5

CLAIMANT CANCER 

DIAGNOSES

Primary Cancer 

#1

Primary Cancer 

#2

Primary Cancer 

#3

Secondary 

Cancer #1

Secondary 

Cancer #2

Secondary 

Cancer #3

Cancer Type

Melanoma 

[redact] neck N/A N/A N/A N/A N/A

Date of Diagnosis N/A N/A N/A N/A N/A N/A

EXPOSURE INFORMATION

Number of exposures

157

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redact] acute photons E=30-250keV Normal 0.011 0.003 0.000

2 [redact] acute photons E>250keV Normal 0.039 0.012 0.000

3 [redact] acute electrons E>15keV Lognormal 0.015 1.520 0.000

4 [redact] acute photons E=30-250keV Lognormal 0.325 1.520 0.000

5 [redact] acute photons E=30-250keV Lognormal 0.050 1.520 0.000

6 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

7 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

8 [redact] acute photons E=30-250keV Lognormal 0.220 1.520 0.000

9 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

10 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

11 [redact] acute photons E=30-250keV Lognormal 0.160 1.520 0.000

12 [redact] acute photons E=30-250keV Lognormal 0.190 1.520 0.000

13 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

14 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

15 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

16 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

17 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

18 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

19 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

20 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

21 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

22 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

23 [redact] acute photons E=30-250keV Lognormal 0.105 1.520 0.000

24 [redact] acute photons E=30-250keV Normal 3.01E-02 0.009 0.000

25 [redact] acute photons E=30-250keV Normal 5.60E-03 0.002 0.000

26 [redact] acute photons E=30-250keV Normal 5.60E-03 0.002 0.000

27 [redact] acute photons E=30-250keV Normal 1.40E-02 0.004 0.000

28 [redact] acute photons E=30-250keV Normal 1.40E-02 0.004 0.000

29 [redact] chronic alpha Constant 0.000 0.000 0.000

30 [redact] chronic alpha Constant 0.000 0.000 0.000

31 [redact] chronic alpha Constant 0.000 0.000 0.000

32 [redact] chronic alpha Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

29 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-5: IREP Input – [Redact] [Redact] Neck #5 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

33 [redact] chronic alpha Constant 0.000 0.000 0.000

34 [redact] chronic alpha Constant 0.000 0.000 0.000

35 [redact] chronic alpha Constant 0.000 0.000 0.000

36 [redact] chronic alpha Constant 0.000 0.000 0.000

37 [redact] chronic alpha Constant 0.000 0.000 0.000

38 [redact] chronic alpha Constant 0.000 0.000 0.000

39 [redact] chronic alpha Constant 0.000 0.000 0.000

40 [redact] chronic alpha Constant 0.000 0.000 0.000

41 [redact] chronic alpha Constant 0.000 0.000 0.000

42 [redact] chronic alpha Constant 0.000 0.000 0.000

43 [redact] chronic alpha Constant 0.000 0.000 0.000

44 [redact] chronic alpha Constant 0.000 0.000 0.000

45 [redact] chronic alpha Constant 0.000 0.000 0.000

46 [redact] chronic alpha Constant 0.000 0.000 0.000

47 [redact] chronic alpha Constant 0.000 0.000 0.000

48 [redact] chronic alpha Constant 0.000 0.000 0.000

49 [redact] chronic alpha Constant 0.000 0.000 0.000

50 [redact] chronic alpha Constant 0.000 0.000 0.000

51 [redact] chronic alpha Constant 0.000 0.000 0.000

52 [redact] chronic alpha Constant 0.000 0.000 0.000

53 [redact] chronic alpha Constant 0.000 0.000 0.000

54 [redact] chronic alpha Constant 0.000 0.000 0.000

55 [redact] chronic alpha Constant 0.000 0.000 0.000

56 [redact] chronic alpha Constant 0.000 0.000 0.000

57 [redact] chronic alpha Constant 0.000 0.000 0.000

58 [redact] chronic alpha Constant 0.000 0.000 0.000

59 [redact] chronic alpha Constant 0.000 0.000 0.000

60 [redact] chronic alpha Constant 0.000 0.000 0.000

61 [redact] chronic alpha Constant 0.000 0.000 0.000

62 [redact] chronic alpha Constant 0.000 0.000 0.000

63 [redact] chronic alpha Constant 0.000 0.000 0.000

64 [redact] chronic alpha Constant 0.000 0.000 0.000

65 [redact] chronic alpha Constant 0.000 0.000 0.000

66 [redact] chronic alpha Constant 0.000 0.000 0.000

67 [redact] chronic alpha Constant 0.000 0.000 0.000

68 [redact] chronic alpha Constant 0.000 0.000 0.000

69 [redact] chronic alpha Constant 0.000 0.000 0.000

70 [redact] chronic alpha Constant 0.000 0.000 0.000

71 [redact] chronic alpha Constant 0.000 0.000 0.000

72 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

73 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

74 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

30 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-5: IREP Input – [Redact] [Redact] Neck #5 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

75 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

76 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

77 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

78 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

79 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

80 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

81 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

82 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

83 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

84 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

85 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

86 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

87 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

88 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

89 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

90 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

91 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

92 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

93 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

94 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

95 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

96 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

97 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

98 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

99 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

100 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

101 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

102 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

103 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

104 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

105 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

106 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

107 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

108 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

109 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

110 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

111 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

112 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

113 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

114 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

115 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

116 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

31 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-5: IREP Input – [Redact] [Redact] Neck #5 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

117 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

118 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

119 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

120 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

121 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

122 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

123 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

124 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

125 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

126 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

127 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

128 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

129 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

130 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

131 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

132 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

133 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

134 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

135 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

136 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

137 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

138 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

139 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

140 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

141 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

142 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

143 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

144 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

145 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

146 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

147 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

148 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

149 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

150 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

151 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

152 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

153 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

154 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

155 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

156 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

157 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

32 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

APPENDIX A-6: IREP INPUT – [REDACT] [REDACT] #6

CLAIMANT CANCER DIAGNOSES

Primary Cancer 

#1

Primary 

Cancer #2

Primary 

Cancer #3

Secondary 

Cancer #1

Secondary 

Cancer #2

Secondary 

Cancer #3

Cancer Type SCC in [redact] N/A N/A N/A N/A N/A

Date of Diagnosis N/A N/A N/A N/A N/A N/A

EXPOSURE INFORMATION

Number of exposures

175

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redact] acute photons E=30-250keV Normal 0.011 0.003 0.000

2 [redact] acute photons E>250keV Normal 0.039 0.012 0.000

3 [redact] acute electrons E>15keV Lognormal 0.015 1.520 0.000

4 [redact] acute photons E=30-250keV Lognormal 0.325 1.520 0.000

5 [redact] acute photons E=30-250keV Lognormal 0.050 1.520 0.000

6 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

7 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

8 [redact] acute photons E=30-250keV Lognormal 0.220 1.520 0.000

9 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

10 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

11 [redact] acute photons E=30-250keV Lognormal 0.160 1.520 0.000

12 [redact] acute photons E=30-250keV Lognormal 0.190 1.520 0.000

13 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

14 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

15 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

16 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

17 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

18 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

19 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

20 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

21 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

22 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

23 [redact] acute photons E=30-250keV Lognormal 0.105 1.520 0.000

24 [redact] acute photons E=30-250keV Normal 4.79E-04 0.000 0.000

25 [redact] acute photons E=30-250keV Normal 1.84E-03 0.001 0.000

26 [redact] acute photons E=30-250keV Normal 1.84E-03 0.001 0.000

27 [redact] acute photons E=30-250keV Normal 1.33E-02 0.004 0.000

28 [redact] acute photons E=30-250keV Normal 1.33E-02 0.004 0.000

29 [redact] chronic alpha Constant 0.000 0.000 0.000

30 [redact] chronic alpha Constant 0.000 0.000 0.000

31 [redact] chronic alpha Constant 0.000 0.000 0.000

32 [redact] chronic alpha Constant 0.000 0.000 0.000

33 [redact] chronic alpha Constant 0.000 0.000 0.000

34 [redact] chronic alpha Constant 0.000 0.000 0.000

35 [redact] chronic alpha Constant 0.000 0.000 0.000

36 [redact] chronic alpha Constant 0.000 0.000 0.000

37 [redact] chronic alpha Constant 0.000 0.000 0.000

38 [redact] chronic alpha Constant 0.000 0.000 0.000

39 [redact] chronic alpha Constant 0.000 0.000 0.000

40 [redact] chronic alpha Constant 0.000 0.000 0.000

41 [redact] chronic alpha Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

33 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-6: IREP Input – [Redact] [Redact] #6 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

42 [redact] chronic alpha Constant 0.000 0.000 0.000

43 [redact] chronic alpha Constant 0.000 0.000 0.000

44 [redact] chronic alpha Constant 0.000 0.000 0.000

45 [redact] chronic alpha Constant 0.000 0.000 0.000

46 [redact] chronic alpha Constant 0.000 0.000 0.000

47 [redact] chronic alpha Constant 0.000 0.000 0.000

48 [redact] chronic alpha Constant 0.000 0.000 0.000

49 [redact] chronic alpha Constant 0.000 0.000 0.000

50 [redact] chronic alpha Constant 0.000 0.000 0.000

51 [redact] chronic alpha Constant 0.000 0.000 0.000

52 [redact] chronic alpha Constant 0.000 0.000 0.000

53 [redact] chronic alpha Constant 0.000 0.000 0.000

54 [redact] chronic alpha Constant 0.000 0.000 0.000

55 [redact] chronic alpha Constant 0.000 0.000 0.000

56 [redact] chronic alpha Constant 0.000 0.000 0.000

57 [redact] chronic alpha Constant 0.000 0.000 0.000

58 [redact] chronic alpha Constant 0.000 0.000 0.000

59 [redact] chronic alpha Constant 0.000 0.000 0.000

60 [redact] chronic alpha Constant 0.000 0.000 0.000

61 [redact] chronic alpha Constant 0.000 0.000 0.000

62 [redact] chronic alpha Constant 0.000 0.000 0.000

63 [redact] chronic alpha Constant 0.000 0.000 0.000

64 [redact] chronic alpha Constant 0.000 0.000 0.000

65 [redact] chronic alpha Constant 0.000 0.000 0.000

66 [redact] chronic alpha Constant 0.000 0.000 0.000

67 [redact] chronic alpha Constant 0.000 0.000 0.000

68 [redact] chronic alpha Constant 0.000 0.000 0.000

69 [redact] chronic alpha Constant 0.000 0.000 0.000

70 [redact] chronic alpha Constant 0.000 0.000 0.000

71 [redact] chronic alpha Constant 0.000 0.000 0.000

72 [redact] chronic alpha Constant 0.000 0.000 0.000

73 [redact] chronic alpha Constant 0.000 0.000 0.000

74 [redact] chronic alpha Constant 0.000 0.000 0.000

75 [redact] chronic alpha Constant 0.000 0.000 0.000

76 [redact] chronic alpha Constant 0.000 0.000 0.000

77 [redact] chronic alpha Constant 0.000 0.000 0.000

78 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

79 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

80 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

81 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

82 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

83 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

84 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

85 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

86 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

87 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

88 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

89 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

90 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

91 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

92 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

93 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

34 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-6: IREP Input – [Redact] [Redact] #6 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

94 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

95 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

96 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

97 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

98 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

99 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

100 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

101 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

102 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

103 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

104 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

105 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

106 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

107 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

108 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

109 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

110 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

111 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

112 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

113 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

114 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

115 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

116 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

117 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

118 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

119 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

120 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

121 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

122 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

123 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

124 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

125 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

126 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

127 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

128 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

129 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

130 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

131 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

132 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

133 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

134 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

135 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

136 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

137 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

138 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

139 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

140 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

141 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

142 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

143 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

144 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

145 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

35 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-6: IREP Input – [Redact] [Redact] #6 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

146 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

147 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

148 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

149 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

150 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

151 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

152 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

153 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

154 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

155 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

156 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

157 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

158 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

159 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

160 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

161 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

162 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

163 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

164 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

165 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

166 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

167 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

168 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

169 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

170 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

171 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

172 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

173 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

174 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

175 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

36 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

APPENDIX A-7: IREP INPUT – [REDACT] THROMBOCYTOSIS #7

CLAIMANT CANCER DIAGNOSES

Primary Cancer 

#1

Primary Cancer 

#2

Primary Cancer 

#3

Secondary 

Cancer #1

Secondary 

Cancer #2

Secondary 

Cancer #3

Cancer Type Thrombocytosis N/A N/A N/A N/A N/A

Date of Diagnosis N/A N/A N/A N/A N/A N/A

EXPOSURE INFORMATION 

Number of exposures

194

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redact] acute photons E=30-250keV Normal 0.007 0.002 0.000

2 [redact] acute photons E>250keV Normal 0.028 0.008 0.000

3 [redact] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

4 [redact] acute photons E=30-250keV Lognormal 0.007 1.520 0.000

5 [redact] acute photons E=30-250keV Lognormal 0.003 1.520 0.000

6 [redact] acute photons E=30-250keV Lognormal 0.033 1.520 0.000

7 [redact] acute photons E=30-250keV Lognormal 0.030 1.520 0.000

8 [redact] acute photons E=30-250keV Lognormal 0.033 1.520 0.000

9 [redact] acute photons E=30-250keV Lognormal 0.033 1.520 0.000

10 [redact] acute photons E=30-250keV Lognormal 0.022 1.520 0.000

11 [redact] acute photons E=30-250keV Lognormal 0.026 1.520 0.000

12 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

13 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

14 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

15 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

16 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

17 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

18 [redact] acute photons E=30-250keV Lognormal 0.023 1.520 0.000

19 [redact] acute photons E=30-250keV Lognormal 0.023 1.520 0.000

20 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

21 [redact] acute photons E=30-250keV Lognormal 0.023 1.520 0.000

22 [redact] acute photons E=30-250keV Lognormal 0.014 1.520 0.000

23 [redact] acute photons E>250keV Lognormal 0.183 1.520 0.000

24 [redact] acute photons E>250keV Lognormal 0.028 1.520 0.000

25 [redact] acute photons E>250keV Lognormal 0.014 1.520 0.000

26 [redact] acute photons E>250keV Lognormal 0.135 1.520 0.000

27 [redact] acute photons E>250keV Lognormal 0.124 1.520 0.000

28 [redact] acute photons E>250keV Lognormal 0.135 1.520 0.000

29 [redact] acute photons E>250keV Lognormal 0.135 1.520 0.000

30 [redact] acute photons E>250keV Lognormal 0.090 1.520 0.000

31 [redact] acute photons E>250keV Lognormal 0.107 1.520 0.000

32 [redact] acute photons E>250keV Lognormal 0.101 1.520 0.000

33 [redact] acute photons E>250keV Lognormal 0.101 1.520 0.000

34 [redact] acute photons E>250keV Lognormal 0.101 1.520 0.000

35 [redact] acute photons E>250keV Lognormal 0.101 1.520 0.000

36 [redact] acute photons E>250keV Lognormal 0.101 1.520 0.000

37 [redact] acute photons E>250keV Lognormal 0.101 1.520 0.000

38 [redact] acute photons E>250keV Lognormal 0.093 1.520 0.000

39 [redact] acute photons E>250keV Lognormal 0.093 1.520 0.000

40 [redact] acute photons E>250keV Lognormal 0.101 1.520 0.000

41 [redact] acute photons E>250keV Lognormal 0.093 1.520 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

37 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-7: IREP Input – [Redact] Thrombocytosis #7 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

42 [redact] acute photons E>250keV Lognormal 0.059 1.520 0.000

43 [redact] acute photons E=30-250keV Normal 0.002 0.007 0.000

44 [redact] acute photons E=30-250keV Normal 0.005 0.001 0.000

45 [redact] acute photons E=30-250keV Normal 0.005 0.001 0.000

46 [redact] acute photons E=30-250keV Normal 0.005 0.004 0.000

47 [redact] acute photons E=30-250keV Normal 0.005 0.004 0.000

48 [redact] chronic alpha Constant 0.001 0.000 0.000

49 [redact] chronic alpha Constant 0.002 0.000 0.000

50 [redact] chronic alpha Constant 0.002 0.000 0.000

51 [redact] chronic alpha Constant 0.003 0.000 0.000

52 [redact] chronic alpha Constant 0.003 0.000 0.000

53 [redact] chronic alpha Constant 0.004 0.000 0.000

54 [redact] chronic alpha Constant 0.004 0.000 0.000

55 [redact] chronic alpha Constant 0.004 0.000 0.000

56 [redact] chronic alpha Constant 0.005 0.000 0.000

57 [redact] chronic alpha Constant 0.005 0.000 0.000

58 [redact] chronic alpha Constant 0.005 0.000 0.000

59 [redact] chronic alpha Constant 0.006 0.000 0.000

60 [redact] chronic alpha Constant 0.006 0.000 0.000

61 [redact] chronic alpha Constant 0.006 0.000 0.000

62 [redact] chronic alpha Constant 0.006 0.000 0.000

63 [redact] chronic alpha Constant 0.007 0.000 0.000

64 [redact] chronic alpha Constant 0.007 0.000 0.000

65 [redact] chronic alpha Constant 0.007 0.000 0.000

66 [redact] chronic alpha Constant 0.007 0.000 0.000

67 [redact] chronic alpha Constant 0.007 0.000 0.000

68 [redact] chronic alpha Constant 0.007 0.000 0.000

69 [redact] chronic alpha Constant 0.007 0.000 0.000

70 [redact] chronic alpha Constant 0.006 0.000 0.000

71 [redact] chronic alpha Constant 0.006 0.000 0.000

72 [redact] chronic alpha Constant 0.005 0.000 0.000

73 [redact] chronic alpha Constant 0.005 0.000 0.000

74 [redact] chronic alpha Constant 0.005 0.000 0.000

75 [redact] chronic alpha Constant 0.004 0.000 0.000

76 [redact] chronic alpha Constant 0.004 0.000 0.000

77 [redact] chronic alpha Constant 0.004 0.000 0.000

78 [redact] chronic alpha Constant 0.004 0.000 0.000

79 [redact] chronic alpha Constant 0.004 0.000 0.000

80 [redact] chronic alpha Constant 0.004 0.000 0.000

81 [redact] chronic alpha Constant 0.004 0.000 0.000

82 [redact] chronic alpha Constant 0.003 0.000 0.000

83 [redact] chronic alpha Constant 0.003 0.000 0.000

84 [redact] chronic alpha Constant 0.003 0.000 0.000

85 [redact] chronic alpha Constant 0.003 0.000 0.000

86 [redact] chronic alpha Constant 0.003 0.000 0.000

87 [redact] chronic alpha Constant 0.003 0.000 0.000

88 [redact] chronic alpha Constant 0.003 0.000 0.000

89 [redact] chronic alpha Constant 0.003 0.000 0.000

90 [redact] chronic alpha Constant 0.003 0.000 0.000

91 [redact] chronic alpha Constant 0.003 0.000 0.000

92 [redact] chronic alpha Constant 0.003 0.000 0.000

93 [redact] chronic alpha Constant 0.003 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

38 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-7: IREP Input – [Redact] Thrombocytosis #7 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

94 [redact] chronic alpha Constant 0.003 0.000 0.000

95 [redact] chronic alpha Constant 0.003 0.000 0.000

96 [redact] chronic alpha Constant 0.002 0.000 0.000

97 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

98 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

99 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

100 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

101 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

102 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

103 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

104 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

105 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

106 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

107 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

108 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

109 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

110 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

111 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

112 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

113 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

114 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

115 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

116 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

117 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

118 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

119 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

120 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

121 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

122 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

123 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

124 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

125 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

126 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

127 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

128 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

129 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

130 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

131 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

132 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

133 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

134 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

135 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

136 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

137 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

138 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

139 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

140 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

141 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

142 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

143 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

144 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

145 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

39 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-7: IREP Input – [Redact] Thrombocytosis #7 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

146 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

147 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

148 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

149 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

150 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

151 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

152 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

153 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

154 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

155 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

156 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

157 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

158 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

159 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

160 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

161 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

162 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

163 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

164 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

165 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

166 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

167 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

168 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

169 [redact] chronic electrons E>15keV Constant 0.001 0.000 0.000

170 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

171 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

172 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

173 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

174 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

175 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

176 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

177 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

178 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

179 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

180 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

181 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

182 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

183 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

184 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

185 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

186 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

187 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

188 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

189 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

190 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

191 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

192 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

193 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

194 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

40 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

APPENDIX A-8: IREP INPUT – [REDACT] [REDACT] #8

CLAIMANT CANCER DIAGNOSES

Primary Cancer #1

Primary 

Cancer #2

Primary 

Cancer #3

Secondary 

Cancer #1

Secondary 

Cancer #2

Secondary 

Cancer #3

Cancer Type SCC in situ [redact] N/A N/A N/A N/A N/A

Date of Diagnosis N/A N/A N/A N/A N/A N/A

EXPOSURE INFORMATION

Number of exposures

178

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redact] acute photons E=30-250keV Normal 0.011 0.003 0.000

2 [redact] acute photons E>250keV Normal 0.039 0.012 0.000

3 [redact] acute electrons E>15keV Lognormal 0.015 1.520 0.000

4 [redact] acute photons E=30-250keV Lognormal 0.325 1.520 0.000

5 [redact] acute photons E=30-250keV Lognormal 0.050 1.520 0.000

6 [redact] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

7 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

8 [redact] acute photons E=30-250keV Lognormal 0.220 1.520 0.000

9 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

10 [redact] acute photons E=30-250keV Lognormal 0.240 1.520 0.000

11 [redact] acute photons E=30-250keV Lognormal 0.160 1.520 0.000

12 [redact] acute photons E=30-250keV Lognormal 0.190 1.520 0.000

13 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

14 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

15 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

16 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

17 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

18 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

19 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

20 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

21 [redact] acute photons E=30-250keV Lognormal 0.180 1.520 0.000

22 [redact] acute photons E=30-250keV Lognormal 0.165 1.520 0.000

23 [redact] acute photons E=30-250keV Lognormal 0.105 1.520 0.000

24 [redact] acute photons E=30-250keV Normal 5.00E-04 0.000 0.000

25 [redact] acute photons E=30-250keV Normal 1.80E-03 0.001 0.000

26 [redact] acute photons E=30-250keV Normal 1.80E-03 0.001 0.000

27 [redact] acute photons E=30-250keV Normal 1.40E-02 0.004 0.000

28 [redact] acute photons E=30-250keV Normal 1.40E-02 0.004 0.000

29 [redact] chronic alpha Constant 0.000 0.000 0.000

30 [redact] chronic alpha Constant 0.000 0.000 0.000

31 [redact] chronic alpha Constant 0.000 0.000 0.000

32 [redact] chronic alpha Constant 0.000 0.000 0.000

33 [redact] chronic alpha Constant 0.000 0.000 0.000

34 [redact] chronic alpha Constant 0.000 0.000 0.000

35 [redact] chronic alpha Constant 0.000 0.000 0.000

36 [redact] chronic alpha Constant 0.000 0.000 0.000

37 [redact] chronic alpha Constant 0.000 0.000 0.000

38 [redact] chronic alpha Constant 0.000 0.000 0.000

39 [redact] chronic alpha Constant 0.000 0.000 0.000

40 [redact] chronic alpha Constant 0.000 0.000 0.000

41 [redact] chronic alpha Constant 0.000 0.000 0.000

42 [redact] chronic alpha Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

41 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-8: IREP Input – [Redact] [Redact] #8 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

43 [redact] chronic alpha Constant 0.000 0.000 0.000

44 [redact] chronic alpha Constant 0.000 0.000 0.000

45 [redact] chronic alpha Constant 0.000 0.000 0.000

46 [redact] chronic alpha Constant 0.000 0.000 0.000

47 [redact] chronic alpha Constant 0.000 0.000 0.000

48 [redact] chronic alpha Constant 0.000 0.000 0.000

49 [redact] chronic alpha Constant 0.000 0.000 0.000

50 [redact] chronic alpha Constant 0.000 0.000 0.000

51 [redact] chronic alpha Constant 0.000 0.000 0.000

52 [redact] chronic alpha Constant 0.000 0.000 0.000

53 [redact] chronic alpha Constant 0.000 0.000 0.000

54 [redact] chronic alpha Constant 0.000 0.000 0.000

55 [redact] chronic alpha Constant 0.000 0.000 0.000

56 [redact] chronic alpha Constant 0.000 0.000 0.000

57 [redact] chronic alpha Constant 0.000 0.000 0.000

58 [redact] chronic alpha Constant 0.000 0.000 0.000

59 [redact] chronic alpha Constant 0.000 0.000 0.000

60 [redact] chronic alpha Constant 0.000 0.000 0.000

61 [redact] chronic alpha Constant 0.000 0.000 0.000

62 [redact] chronic alpha Constant 0.000 0.000 0.000

63 [redact] chronic alpha Constant 0.000 0.000 0.000

64 [redact] chronic alpha Constant 0.000 0.000 0.000

65 [redact] chronic alpha Constant 0.000 0.000 0.000

66 [redact] chronic alpha Constant 0.000 0.000 0.000

67 [redact] chronic alpha Constant 0.000 0.000 0.000

68 [redact] chronic alpha Constant 0.000 0.000 0.000

69 [redact] chronic alpha Constant 0.000 0.000 0.000

70 [redact] chronic alpha Constant 0.000 0.000 0.000

71 [redact] chronic alpha Constant 0.000 0.000 0.000

72 [redact] chronic alpha Constant 0.000 0.000 0.000

73 [redact] chronic alpha Constant 0.000 0.000 0.000

74 [redact] chronic alpha Constant 0.000 0.000 0.000

75 [redact] chronic alpha Constant 0.000 0.000 0.000

76 [redact] chronic alpha Constant 0.000 0.000 0.000

77 [redact] chronic alpha Constant 0.000 0.000 0.000

78 [redact] chronic alpha Constant 0.000 0.000 0.000

79 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

80 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

81 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

82 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

83 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

84 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

85 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

86 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

87 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

88 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

89 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

90 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

91 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

92 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

93 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

94 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

42 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-8: IREP Input – [Redact] [Redact] #8 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

95 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

96 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

97 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

98 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

99 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

100 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

101 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

102 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

103 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

104 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

105 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

106 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

107 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

108 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

109 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

110 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

111 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

112 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

113 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

114 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

115 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

116 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

117 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

118 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

119 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

120 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

121 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

122 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

123 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

124 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

125 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

126 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

127 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

128 [redact] chronic photons E>250keV Constant 0.000 0.000 0.000

129 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

130 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

131 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

132 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

133 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

134 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

135 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

136 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

137 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

138 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

139 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

140 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

141 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

142 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

143 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

144 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

145 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

146 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000
Effective Date:

February 12, 2015

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2015-CN[Redact]

Page No.

43 of 43

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82. 

Appendix A-8: IREP Input – [Redact] [Redact] #8 (continued)

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

147 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

148 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

149 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

150 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

151 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

152 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

153 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

154 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

155 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

156 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

157 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

158 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

159 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

160 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

161 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

162 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

163 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

164 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

165 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

166 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

167 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

168 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

169 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

170 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

171 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

172 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

173 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

174 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

175 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

176 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

177 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000

178 [redact] chronic electrons E>15keV Constant 0.000 0.000 0.000